| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | MED15 TCF4 NCOA6 JUND ARID1B MED30 HDAC5 IRF2BP1 ZMIZ2 MED14 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 SSBP3 ARID1A IFI16 CREBBP MAML3 | 1.74e-17 | 562 | 63 | 21 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA6 JUND ARID1B MED30 ZMIZ2 MED14 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 SSBP3 ARID1A CREBBP MAML3 | 1.03e-15 | 303 | 63 | 16 | GO:0003713 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | MED15 TCF4 NCOA6 JUND ARID1B MED30 HDAC5 SH3RF1 IRF2BP1 MAPT ZMIZ2 MED14 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 SSBP3 ARID1A IFI16 CREBBP MAML3 | 3.04e-13 | 1160 | 63 | 23 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | MED15 TCF4 NCOA6 JUND ARID1B MED30 HDAC5 SH3RF1 IRF2BP1 MAPT ZMIZ2 ITSN1 MED14 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 SSBP3 ARID1A IFI16 CREBBP MAML3 | 9.07e-13 | 1356 | 63 | 24 | GO:0060090 |
| GeneOntologyMolecularFunction | chromatin binding | TCF4 NCOA6 ARID1B ERCC6 HDAC5 PELP1 POLR2A SMARCA2 SMARCA4 AUTS2 SMARCC2 SMARCD2 SMARCD3 ARID1A FOXA2 CREBBP | 7.61e-10 | 739 | 63 | 16 | GO:0003682 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 3.75e-08 | 61 | 63 | 6 | GO:0030374 | |
| GeneOntologyMolecularFunction | transcription factor binding | TCF4 NCOA6 JUND MED30 HDAC5 IRF2BP1 PITX1 MED14 SMARCA4 SMARCD3 ARID1A FOXA2 IFI16 CREBBP | 7.01e-08 | 753 | 63 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | NCOA6 JUND MED30 HDAC5 PITX1 MED14 SMARCA4 SMARCD3 ARID1A CREBBP | 6.74e-07 | 417 | 63 | 10 | GO:0061629 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | TCF4 NCOA6 JUND MED30 HDAC5 PITX1 MED14 SMARCA4 SMARCD3 ARID1A CREBBP | 1.83e-06 | 582 | 63 | 11 | GO:0140297 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 2.01e-06 | 187 | 63 | 7 | GO:0016922 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 5.49e-06 | 37 | 63 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | nucleosome binding | 1.44e-05 | 98 | 63 | 5 | GO:0031491 | |
| GeneOntologyMolecularFunction | nuclear vitamin D receptor binding | 2.36e-05 | 18 | 63 | 3 | GO:0042809 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 8.00e-05 | 140 | 63 | 5 | GO:0001221 | |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 1.46e-04 | 6 | 63 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 6.96e-04 | 127 | 63 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 7.77e-04 | 229 | 63 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | nucleosomal DNA binding | 1.24e-03 | 67 | 63 | 3 | GO:0031492 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.79e-03 | 20 | 63 | 2 | GO:0061665 | |
| GeneOntologyMolecularFunction | myosin V binding | 1.79e-03 | 20 | 63 | 2 | GO:0031489 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.92e-03 | 167 | 63 | 4 | GO:0031490 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 1.98e-03 | 21 | 63 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | SMAD binding | 2.54e-03 | 86 | 63 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 3.27e-03 | 27 | 63 | 2 | GO:0001091 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 2.60e-12 | 29 | 63 | 7 | GO:2000819 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | ARID1B ERCC6 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 1.22e-11 | 95 | 63 | 9 | GO:2000781 |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | ARID1B ERCC6 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP INO80D | 1.74e-11 | 143 | 63 | 10 | GO:0045739 |
| GeneOntologyBiologicalProcess | regulation of double-strand break repair | ARID1B ERCC6 CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 2.15e-11 | 146 | 63 | 10 | GO:2000779 |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 4.36e-11 | 42 | 63 | 7 | GO:0070316 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | MED15 TCF4 NCOA6 JUND MED30 ERCC6 HDAC5 PELP1 ZMIZ2 TBX21 PITX1 MED14 SMARCA2 SMARCA4 AUTS2 ZMIZ1 SSBP4 SSBP3 FOXA2 IFI16 CREBBP MAML3 | 5.22e-11 | 1390 | 63 | 22 | GO:0045944 |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 6.17e-11 | 44 | 63 | 7 | GO:0045023 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | ARID1B ERCC6 CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP INO80D | 1.16e-10 | 234 | 63 | 11 | GO:0006282 |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 2.54e-10 | 88 | 63 | 8 | GO:0006289 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 2.78e-10 | 54 | 63 | 7 | GO:0045663 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | ARID1B SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 1.57e-09 | 226 | 63 | 10 | GO:0045580 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | MED15 TCF4 ARID1B MED30 ERCC6 HDAC5 MED14 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A FOXA2 IFI16 CREBBP INO80D | 4.78e-09 | 999 | 63 | 17 | GO:0071824 |
| GeneOntologyBiologicalProcess | positive regulation of DNA metabolic process | ARID1B ERCC6 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP INO80D | 4.80e-09 | 333 | 63 | 11 | GO:0051054 |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 5.72e-09 | 22 | 63 | 5 | GO:0006337 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | ARID1B SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 7.53e-09 | 266 | 63 | 10 | GO:0045619 |
| GeneOntologyBiologicalProcess | myoblast differentiation | 8.29e-09 | 136 | 63 | 8 | GO:0045445 | |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 9.19e-09 | 24 | 63 | 5 | GO:0032986 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | ARID1B CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A | 9.84e-09 | 139 | 63 | 8 | GO:0051983 |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 1.26e-08 | 92 | 63 | 7 | GO:0045661 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.30e-08 | 144 | 63 | 8 | GO:0045582 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 1.58e-08 | 95 | 63 | 7 | GO:0030071 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 1.96e-08 | 98 | 63 | 7 | GO:1902099 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 2.25e-08 | 100 | 63 | 7 | GO:0007091 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | ARID1B ERCC6 MAPT CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 TAOK1 ARID1A CREBBP INO80D | 2.49e-08 | 598 | 63 | 13 | GO:0080135 |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 2.77e-08 | 103 | 63 | 7 | GO:0044784 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 3.27e-08 | 162 | 63 | 8 | GO:0045621 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 4.66e-08 | 111 | 63 | 7 | GO:0033045 | |
| GeneOntologyBiologicalProcess | double-strand break repair | ARID1B ERCC6 CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 4.87e-08 | 324 | 63 | 10 | GO:0006302 |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | ARID1B MAPT SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A INO80D | 1.11e-07 | 266 | 63 | 9 | GO:0033044 |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | ARID1B ERCC6 CSNK2A1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP INO80D | 1.16e-07 | 564 | 63 | 12 | GO:0051052 |
| GeneOntologyBiologicalProcess | regulation of T cell activation | ILDR2 ARID1B SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 1.25e-07 | 458 | 63 | 11 | GO:0050863 |
| GeneOntologyBiologicalProcess | DNA damage response | NCOA6 ARID1B ERCC6 MAPT CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 TAOK1 ARID1A IFI16 CREBBP INO80D | 1.38e-07 | 959 | 63 | 15 | GO:0006974 |
| GeneOntologyBiologicalProcess | T cell differentiation | ARID1B SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 2.25e-07 | 382 | 63 | 10 | GO:0030217 |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 2.70e-07 | 213 | 63 | 8 | GO:2000045 |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | ARID1B HDAC5 SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A IFI16 | 4.51e-07 | 640 | 63 | 12 | GO:1903131 |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 5.00e-07 | 231 | 63 | 8 | GO:0006352 | |
| GeneOntologyBiologicalProcess | DNA repair | ARID1B ERCC6 CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 TAOK1 ARID1A CREBBP INO80D | 5.15e-07 | 648 | 63 | 12 | GO:0006281 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | JUND ARID1B TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 5.73e-07 | 423 | 63 | 10 | GO:0002696 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 6.07e-07 | 237 | 63 | 8 | GO:0019827 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | ARID1B HDAC5 SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 6.09e-07 | 537 | 63 | 11 | GO:0030098 |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | ARID1B SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 6.52e-07 | 429 | 63 | 10 | GO:1902105 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 7.10e-07 | 242 | 63 | 8 | GO:1902107 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 7.10e-07 | 242 | 63 | 8 | GO:0098727 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 7.10e-07 | 242 | 63 | 8 | GO:1903708 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 8.04e-07 | 246 | 63 | 8 | GO:1902806 |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | ILDR2 ARID1B TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 9.46e-07 | 447 | 63 | 10 | GO:1903037 |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | JUND ARID1B TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 9.85e-07 | 449 | 63 | 10 | GO:0050867 |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | ILDR2 JUND ARID1B SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 1.06e-06 | 694 | 63 | 12 | GO:0002694 |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | ILDR2 ARID1B TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A FOXA2 | 1.29e-06 | 580 | 63 | 11 | GO:0022407 |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 1.56e-06 | 186 | 63 | 7 | GO:0006367 | |
| GeneOntologyBiologicalProcess | G1/S transition of mitotic cell cycle | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 1.66e-06 | 271 | 63 | 8 | GO:0000082 |
| GeneOntologyBiologicalProcess | leukocyte cell-cell adhesion | ILDR2 ARID1B TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 2.01e-06 | 486 | 63 | 10 | GO:0007159 |
| GeneOntologyBiologicalProcess | chromatin remodeling | ARID1B ERCC6 HDAC5 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A IFI16 CREBBP INO80D | 2.10e-06 | 741 | 63 | 12 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | ILDR2 ARID1B SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 2.25e-06 | 614 | 63 | 11 | GO:0051249 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | ARID1B TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 2.44e-06 | 385 | 63 | 9 | GO:0051251 |
| GeneOntologyBiologicalProcess | chromatin organization | ARID1B ERCC6 HDAC5 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A FOXA2 IFI16 CREBBP INO80D | 2.51e-06 | 896 | 63 | 13 | GO:0006325 |
| GeneOntologyBiologicalProcess | regulation of cell activation | ILDR2 JUND ARID1B SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 2.58e-06 | 756 | 63 | 12 | GO:0050865 |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A FOXA2 | 2.65e-06 | 389 | 63 | 9 | GO:0022409 |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 2.75e-06 | 290 | 63 | 8 | GO:0050870 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle phase transition | ARID1B ERCC6 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 TAOK1 ARID1A CREBBP | 3.42e-06 | 516 | 63 | 10 | GO:1901987 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle phase transition | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 TAOK1 ARID1A CREBBP | 3.47e-06 | 402 | 63 | 9 | GO:1901990 |
| GeneOntologyBiologicalProcess | leukocyte differentiation | ARID1B HDAC5 SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A IFI16 | 4.00e-06 | 789 | 63 | 12 | GO:0002521 |
| GeneOntologyBiologicalProcess | cell cycle G1/S phase transition | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 4.09e-06 | 306 | 63 | 8 | GO:0044843 |
| GeneOntologyBiologicalProcess | nucleosome organization | 4.71e-06 | 142 | 63 | 6 | GO:0034728 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | ARID1B SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 5.12e-06 | 540 | 63 | 10 | GO:1903706 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 5.30e-06 | 317 | 63 | 8 | GO:1903039 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | TCF4 JUND ARID1B MAPT SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 LTBP3 ZMIZ1 ARID1A FOXA2 IFI16 | 6.78e-06 | 1141 | 63 | 14 | GO:0045597 |
| GeneOntologyBiologicalProcess | T cell activation | ILDR2 ARID1B SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 7.95e-06 | 701 | 63 | 11 | GO:0042110 |
| GeneOntologyBiologicalProcess | cell activation | ILDR2 TCF4 JUND ARID1B HDAC5 SH3RF1 MAPT TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 1.04e-05 | 1356 | 63 | 15 | GO:0001775 |
| GeneOntologyBiologicalProcess | leukocyte activation | ILDR2 JUND ARID1B HDAC5 SH3RF1 MAPT TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 1.05e-05 | 1186 | 63 | 14 | GO:0045321 |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 1.22e-05 | 254 | 63 | 7 | GO:0000819 | |
| GeneOntologyBiologicalProcess | hemopoiesis | NCOA6 ARID1B HDAC5 SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 SSBP3 ARID1A IFI16 | 1.49e-05 | 1223 | 63 | 14 | GO:0030097 |
| GeneOntologyBiologicalProcess | cell cycle phase transition | ARID1B ERCC6 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 TAOK1 ARID1A CREBBP | 1.88e-05 | 627 | 63 | 10 | GO:0044770 |
| GeneOntologyBiologicalProcess | DNA metabolic process | ARID1B ERCC6 CSNK2A1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 TAOK1 ARID1A CREBBP INO80D | 1.90e-05 | 1081 | 63 | 13 | GO:0006259 |
| GeneOntologyBiologicalProcess | regulation of cell cycle | JUND ARID1B ERCC6 CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 TAOK1 ARID1A CSNK2A3 CREBBP INO80D | 2.01e-05 | 1256 | 63 | 14 | GO:0051726 |
| GeneOntologyBiologicalProcess | mitotic cell cycle phase transition | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 TAOK1 ARID1A CREBBP | 2.29e-05 | 509 | 63 | 9 | GO:0044772 |
| GeneOntologyBiologicalProcess | lymphocyte activation | ILDR2 ARID1B HDAC5 SH3RF1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 3.37e-05 | 976 | 63 | 12 | GO:0046649 |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription, elongation | 3.86e-05 | 62 | 63 | 4 | GO:0032786 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | ARID1B ERCC6 CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 TAOK1 ARID1A CREBBP | 4.48e-05 | 845 | 63 | 11 | GO:0010564 |
| GeneOntologyBiologicalProcess | positive regulation of transcription initiation by RNA polymerase II | 6.23e-05 | 70 | 63 | 4 | GO:0060261 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A FOXA2 | 6.24e-05 | 579 | 63 | 9 | GO:0045785 |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 TAOK1 ARID1A CREBBP | 7.59e-05 | 594 | 63 | 9 | GO:0007346 |
| GeneOntologyBiologicalProcess | positive regulation of immune system process | JUND ARID1B TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A IFI16 PSPC1 CREBBP | 7.99e-05 | 1242 | 63 | 13 | GO:0002684 |
| GeneOntologyBiologicalProcess | chromosome segregation | ARID1B CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A | 8.21e-05 | 465 | 63 | 8 | GO:0007059 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ILDR2 ARID1B TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 CDHR5 ZMIZ1 ARID1A FOXA2 | 8.71e-05 | 1077 | 63 | 12 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of DNA-templated transcription initiation | 9.05e-05 | 77 | 63 | 4 | GO:2000144 | |
| GeneOntologyBiologicalProcess | head development | NCOA6 SALL3 KIF26A PITX1 SMARCA4 GRIA1 ZMIZ1 SSBP3 ARID1A FOXA2 CREBBP | 9.52e-05 | 919 | 63 | 11 | GO:0060322 |
| GeneOntologyBiologicalProcess | positive regulation of cell development | ARID1B MAPT SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 9.76e-05 | 614 | 63 | 9 | GO:0010720 |
| GeneOntologyBiologicalProcess | regulation of cell development | ARID1B HDAC5 SH3RF1 MAPT TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A | 1.02e-04 | 1095 | 63 | 12 | GO:0060284 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | ILDR2 ARID1B TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A FOXA2 | 1.03e-04 | 927 | 63 | 11 | GO:0030155 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | 1.04e-04 | 356 | 63 | 7 | GO:0098813 | |
| GeneOntologyBiologicalProcess | regulation of transcription initiation by RNA polymerase II | 1.10e-04 | 81 | 63 | 4 | GO:0060260 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | 1.11e-04 | 249 | 63 | 6 | GO:0065004 | |
| GeneOntologyBiologicalProcess | transcription preinitiation complex assembly | 1.33e-04 | 85 | 63 | 4 | GO:0070897 | |
| GeneOntologyBiologicalProcess | aortic smooth muscle cell differentiation | 1.37e-04 | 6 | 63 | 2 | GO:0035887 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription initiation | 1.73e-04 | 91 | 63 | 4 | GO:2000142 | |
| GeneOntologyBiologicalProcess | regulation of transcription elongation by RNA polymerase II | 1.88e-04 | 93 | 63 | 4 | GO:0034243 | |
| GeneOntologyBiologicalProcess | chromosome organization | ARID1B MAPT SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A INO80D | 2.24e-04 | 686 | 63 | 9 | GO:0051276 |
| GeneOntologyBiologicalProcess | central nervous system development | NCOA6 SALL3 KIF26A MAPT PITX1 SMARCA4 GRIA1 TAOK1 ZMIZ1 SSBP3 ARID1A FOXA2 | 2.35e-04 | 1197 | 63 | 12 | GO:0007417 |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 2.54e-04 | 185 | 63 | 5 | GO:0035107 | |
| GeneOntologyCellularComponent | bBAF complex | 1.35e-13 | 10 | 64 | 6 | GO:0140092 | |
| GeneOntologyCellularComponent | npBAF complex | 1.91e-12 | 14 | 64 | 6 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 1.91e-12 | 14 | 64 | 6 | GO:0035060 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 3.46e-12 | 30 | 64 | 7 | GO:0016514 | |
| GeneOntologyCellularComponent | nBAF complex | 5.06e-12 | 16 | 64 | 6 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | ARID1B ERCC6 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A INO80D | 1.39e-11 | 96 | 64 | 9 | GO:0070603 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | MED15 TCF4 NCOA6 JUND ARID1B MED30 ERCC6 HDAC5 PELP1 CSNK2A1 POLR2A NPAP1 MED14 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A SRRM2 CREBBP INO80D | 4.80e-11 | 1377 | 64 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | ATPase complex | ARID1B ERCC6 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A INO80D | 2.02e-10 | 129 | 64 | 9 | GO:1904949 |
| GeneOntologyCellularComponent | chromatin | TCF4 JUND ARID1B ERCC6 HDAC5 PELP1 CSNK2A1 ZMIZ2 POLR2A TBX21 PITX1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A FOXA2 CREBBP INO80D | 1.32e-09 | 1480 | 64 | 21 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | MED15 TCF4 NCOA6 JUND MED30 HDAC5 PITX1 MED14 SSBP3 FOXA2 CREBBP | 1.74e-06 | 596 | 64 | 11 | GO:0005667 |
| GeneOntologyCellularComponent | RSC-type complex | 1.21e-05 | 15 | 64 | 3 | GO:0016586 | |
| GeneOntologyCellularComponent | protein kinase CK2 complex | 5.51e-05 | 4 | 64 | 2 | GO:0005956 | |
| GeneOntologyCellularComponent | core mediator complex | 6.77e-05 | 26 | 64 | 3 | GO:0070847 | |
| GeneOntologyCellularComponent | nuclear periphery | 1.78e-04 | 171 | 64 | 5 | GO:0034399 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 1.83e-04 | 272 | 64 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | GBAF complex | 8.20e-04 | 14 | 64 | 2 | GO:0140288 | |
| GeneOntologyCellularComponent | dendritic spine | 8.72e-04 | 242 | 64 | 5 | GO:0043197 | |
| GeneOntologyCellularComponent | nuclear matrix | 8.97e-04 | 140 | 64 | 4 | GO:0016363 | |
| GeneOntologyCellularComponent | neuron spine | 9.56e-04 | 247 | 64 | 5 | GO:0044309 | |
| GeneOntologyCellularComponent | euchromatin | 1.40e-03 | 72 | 64 | 3 | GO:0000791 | |
| GeneOntologyCellularComponent | nuclear body | 1.64e-03 | 903 | 64 | 9 | GO:0016604 | |
| GeneOntologyCellularComponent | nuclear speck | 2.03e-03 | 431 | 64 | 6 | GO:0016607 | |
| GeneOntologyCellularComponent | kinetochore | 2.30e-03 | 181 | 64 | 4 | GO:0000776 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 2.91e-03 | 193 | 64 | 4 | GO:0000779 | |
| GeneOntologyCellularComponent | cell leading edge | 4.22e-03 | 500 | 64 | 6 | GO:0031252 | |
| HumanPheno | Abnormal upper lip morphology | TCF4 ARID1B ERCC6 KIF26A CSNK2A1 IQSEC2 PITX1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 TAOK1 LTBP3 ZMIZ1 ARID1A FOXA2 SRRM2 CREBBP | 9.91e-09 | 980 | 27 | 19 | HP:0000177 |
| HumanPheno | Autistic behavior | TCF4 ARID1B MAPT POLR2A IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 2.57e-08 | 678 | 27 | 16 | HP:0000729 |
| HumanPheno | Abnormal lip morphology | TCF4 ARID1B ERCC6 KIF26A CSNK2A1 IQSEC2 PITX1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 LTBP3 ZMIZ1 ARID1A FOXA2 SRRM2 CREBBP | 7.81e-08 | 1249 | 27 | 20 | HP:0000159 |
| HumanPheno | Diagnostic behavioral phenotype | TCF4 ARID1B MAPT POLR2A IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 1.05e-07 | 747 | 27 | 16 | HP:0025783 |
| HumanPheno | Hyperactivity | ARID1B CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 1.58e-07 | 558 | 27 | 14 | HP:0000752 |
| HumanPheno | Wide nasal base | 2.56e-07 | 28 | 27 | 5 | HP:0012810 | |
| HumanPheno | Short philtrum | TCF4 ARID1B KIF26A IQSEC2 SMARCA2 SMARCA4 AUTS2 TAOK1 ARID1A CREBBP | 3.05e-07 | 253 | 27 | 10 | HP:0000322 |
| HumanPheno | Disinhibition | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 3.18e-07 | 807 | 27 | 16 | HP:0000734 |
| HumanPheno | Inappropriate behavior | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 3.18e-07 | 807 | 27 | 16 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 3.18e-07 | 807 | 27 | 16 | HP:5200123 |
| HumanPheno | Social disinhibition | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 3.18e-07 | 807 | 27 | 16 | HP:5200029 |
| HumanPheno | Abnormal nasal base norphology | 3.68e-07 | 30 | 27 | 5 | HP:0012808 | |
| HumanPheno | Hypertrichosis | ARID1B ERCC6 KIF26A CSNK2A1 IQSEC2 SMARCA2 SMARCA4 SMARCC2 SMARCD2 LTBP3 ARID1A CREBBP | 5.33e-07 | 425 | 27 | 12 | HP:0000998 |
| HumanPheno | Aggressive behavior | TCF4 ARID1B MAPT IQSEC2 NPAP1 SMARCA2 SMARCA4 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A CREBBP | 5.38e-07 | 516 | 27 | 13 | HP:0000718 |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | TCF4 ARID1B MAPT IQSEC2 NPAP1 SMARCA2 SMARCA4 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A CREBBP | 5.38e-07 | 516 | 27 | 13 | HP:0006919 |
| HumanPheno | Abnormality of the philtrum | TCF4 ARID1B ERCC6 KIF26A IQSEC2 SMARCA2 SMARCA4 AUTS2 SMARCC2 TAOK1 LTBP3 ZMIZ1 ARID1A SRRM2 CREBBP | 5.79e-07 | 726 | 27 | 15 | HP:0000288 |
| HumanPheno | Hypoplastic fifth fingernail | 6.05e-07 | 14 | 27 | 4 | HP:0008398 | |
| HumanPheno | Abnormal eyelid morphology | TCF4 SEC24D ARID1B ERCC6 KIF26A MAPT CSNK2A1 IQSEC2 PITX1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 LTBP3 ZMIZ1 ARID1A SRRM2 CREBBP | 6.63e-07 | 1408 | 27 | 20 | HP:0000492 |
| HumanPheno | Abnormally increased volition | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 9.05e-07 | 869 | 27 | 16 | HP:5200263 |
| HumanPheno | Prominent eyelashes | 1.42e-06 | 17 | 27 | 4 | HP:0011231 | |
| HumanPheno | Oral aversion | 1.42e-06 | 17 | 27 | 4 | HP:0012523 | |
| HumanPheno | Thick nasal alae | 1.44e-06 | 39 | 27 | 5 | HP:0009928 | |
| HumanPheno | Abnormal nasal bridge morphology | TCF4 ARID1B ERCC6 CSNK2A1 IQSEC2 PITX1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 TAOK1 LTBP3 ZMIZ1 ARID1A CTSD CREBBP | 1.47e-06 | 1029 | 27 | 17 | HP:0000422 |
| HumanPheno | Abnormal social development | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 1.67e-06 | 908 | 27 | 16 | HP:0025732 |
| HumanPheno | Abnormal hair pattern | TCF4 ARID1B ERCC6 KIF26A CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 LTBP3 ARID1A CREBBP | 1.74e-06 | 676 | 27 | 14 | HP:0010720 |
| HumanPheno | Abnormality of dental eruption | TCF4 SEC24D ARID1B ERCC6 IQSEC2 SMARCA4 SMARCC2 ARID1A CREBBP | 2.19e-06 | 240 | 27 | 9 | HP:0006292 |
| HumanPheno | Hypoplastic fifth toenail | 2.30e-06 | 19 | 27 | 4 | HP:0011937 | |
| HumanPheno | Prominent interphalangeal joints | 2.63e-06 | 6 | 27 | 3 | HP:0006237 | |
| HumanPheno | Broad philtrum | 2.99e-06 | 45 | 27 | 5 | HP:0000289 | |
| HumanPheno | Abnormal hand morphology | TCF4 ARID1B ERCC6 MAPT CSNK2A1 IQSEC2 PITX1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 LTBP3 ZMIZ1 ARID1A CTSD CREBBP | 3.08e-06 | 1082 | 27 | 17 | HP:0005922 |
| HumanPheno | Abnormal eating behavior | 3.14e-06 | 128 | 27 | 7 | HP:0100738 | |
| HumanPheno | Delayed eruption of teeth | 3.19e-06 | 185 | 27 | 8 | HP:0000684 | |
| HumanPheno | Long eyelashes | 3.30e-06 | 129 | 27 | 7 | HP:0000527 | |
| HumanPheno | Wide nasal bridge | TCF4 ARID1B ERCC6 CSNK2A1 IQSEC2 SMARCA2 SMARCA4 AUTS2 LTBP3 ZMIZ1 CTSD CREBBP | 3.64e-06 | 508 | 27 | 12 | HP:0000431 |
| HumanPheno | Papillary thyroid carcinoma | 6.19e-06 | 24 | 27 | 4 | HP:0002895 | |
| HumanPheno | Thick vermilion border | TCF4 ARID1B SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 LTBP3 ARID1A | 7.63e-06 | 279 | 27 | 9 | HP:0012471 |
| HumanPheno | Motor stereotypy | 7.86e-06 | 280 | 27 | 9 | HP:0000733 | |
| HumanPheno | Recurrent respiratory infections | ARID1B ERCC6 POLR2A IQSEC2 NPAP1 SMARCA2 SMARCA4 SMARCC2 GRIA1 SMARCD2 TAOK1 ARID1A CREBBP | 9.07e-06 | 660 | 27 | 13 | HP:0002205 |
| HumanPheno | Feeding difficulties | TCF4 ARID1B ERCC6 CSNK2A1 POLR2A IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 9.35e-06 | 1168 | 27 | 17 | HP:0011968 |
| HumanPheno | Restricted or repetitive behaviors or interests | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 SMARCA2 AUTS2 GRIA1 TAOK1 CREBBP | 9.50e-06 | 368 | 27 | 10 | HP:0031432 |
| HumanPheno | Reduced impulse control | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 9.72e-06 | 1032 | 27 | 16 | HP:5200045 |
| HumanPheno | Deficiency of speech development | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 SMARCA2 SMARCA4 SMARCC2 GRIA1 ARID1A CREBBP | 1.05e-05 | 463 | 27 | 11 | HP:0002116 |
| HumanPheno | Brachydactyly | ARID1B KIF26A CSNK2A1 IQSEC2 PITX1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 LTBP3 ZMIZ1 ARID1A CREBBP | 1.07e-05 | 670 | 27 | 13 | HP:0001156 |
| HumanPheno | Thick eyebrow | 1.08e-05 | 154 | 27 | 7 | HP:0000574 | |
| HumanPheno | Abnormality of upper lip vermillion | ARID1B CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 SMARCC2 ZMIZ1 ARID1A SRRM2 CREBBP | 1.08e-05 | 464 | 27 | 11 | HP:0011339 |
| HumanPheno | Short digit | ARID1B KIF26A CSNK2A1 IQSEC2 PITX1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 LTBP3 ZMIZ1 ARID1A CREBBP | 1.11e-05 | 672 | 27 | 13 | HP:0011927 |
| HumanPheno | Macrostomia | 1.16e-05 | 220 | 27 | 8 | HP:0000181 | |
| HumanPheno | Wide mouth | 1.16e-05 | 220 | 27 | 8 | HP:0000154 | |
| HumanPheno | Hepatoblastoma | 1.18e-05 | 28 | 27 | 4 | HP:0002884 | |
| HumanPheno | Perseverative thought | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 SMARCA2 AUTS2 GRIA1 TAOK1 CREBBP | 1.18e-05 | 377 | 27 | 10 | HP:0030223 |
| HumanPheno | Constipation | TCF4 MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 GRIA1 TAOK1 ZMIZ1 FOXA2 CREBBP | 1.27e-05 | 472 | 27 | 11 | HP:0002019 |
| HumanPheno | Respiratory tract infection | ARID1B ERCC6 POLR2A IQSEC2 NPAP1 SMARCA2 SMARCA4 SMARCC2 GRIA1 SMARCD2 TAOK1 LTBP3 ARID1A CREBBP | 1.28e-05 | 797 | 27 | 14 | HP:0011947 |
| HumanPheno | Clinodactyly | TCF4 ARID1B CSNK2A1 IQSEC2 PITX1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 ARID1A CREBBP | 1.32e-05 | 574 | 27 | 12 | HP:0030084 |
| HumanPheno | Disordered formal thought process | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 SMARCA2 AUTS2 GRIA1 TAOK1 CREBBP | 1.45e-05 | 386 | 27 | 10 | HP:0025769 |
| HumanPheno | Pneumonia | ARID1B ERCC6 SMARCA2 SMARCA4 SMARCC2 SMARCD2 LTBP3 ARID1A CREBBP | 1.85e-05 | 311 | 27 | 9 | HP:0002090 |
| HumanPheno | Inguinal hernia | ARID1B CSNK2A1 POLR2A SMARCA2 AUTS2 SMARCC2 PLD1 ARID1A CREBBP | 1.90e-05 | 312 | 27 | 9 | HP:0000023 |
| HumanPheno | Abnormality of refraction | TCF4 ARID1B ERCC6 IQSEC2 NPAP1 SMARCA4 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 2.01e-05 | 709 | 27 | 13 | HP:0000539 |
| HumanPheno | Abnormal thought pattern | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 SMARCA2 AUTS2 GRIA1 TAOK1 CREBBP | 2.17e-05 | 404 | 27 | 10 | HP:5200269 |
| HumanPheno | Scoliosis | TCF4 SEC24D ARID1B ERCC6 MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 LTBP3 ZMIZ1 ARID1A CREBBP | 2.98e-05 | 1122 | 27 | 16 | HP:0002650 |
| HumanPheno | Delayed speech and language development | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 3.02e-05 | 1123 | 27 | 16 | HP:0000750 |
| HumanPheno | Abnormality of mouth size | TCF4 ARID1B SMARCA2 SMARCA4 AUTS2 SMARCC2 LTBP3 ZMIZ1 ARID1A CREBBP | 3.39e-05 | 425 | 27 | 10 | HP:0011337 |
| HumanPheno | Thin corpus callosum | TCF4 ARID1B ERCC6 KIF26A POLR2A IQSEC2 PITX1 SMARCA2 SMARCA4 SMARCC2 ZMIZ1 ARID1A FOXA2 CREBBP | 3.51e-05 | 868 | 27 | 14 | HP:0033725 |
| HumanPheno | Thin upper lip vermilion | ARID1B CSNK2A1 NPAP1 SMARCA2 SMARCA4 SMARCC2 ARID1A SRRM2 CREBBP | 3.69e-05 | 339 | 27 | 9 | HP:0000219 |
| HumanPheno | Thin lips | ARID1B CSNK2A1 NPAP1 SMARCA2 SMARCA4 SMARCC2 ARID1A SRRM2 CREBBP | 3.69e-05 | 339 | 27 | 9 | HP:0000213 |
| HumanPheno | Postnatal growth retardation | 3.72e-05 | 258 | 27 | 8 | HP:0008897 | |
| HumanPheno | Impairment in personality functioning | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 3.73e-05 | 1141 | 27 | 16 | HP:0031466 |
| HumanPheno | Thin vermilion border | ARID1B ERCC6 CSNK2A1 NPAP1 SMARCA2 SMARCA4 SMARCC2 ARID1A SRRM2 CREBBP | 3.99e-05 | 433 | 27 | 10 | HP:0000233 |
| HumanPheno | Absent speech | TCF4 ARID1B CSNK2A1 IQSEC2 SMARCA2 SMARCA4 SMARCC2 GRIA1 ARID1A CREBBP | 4.23e-05 | 436 | 27 | 10 | HP:0001344 |
| HumanPheno | Aplasia/Hypoplasia of the corpus callosum | TCF4 ARID1B ERCC6 KIF26A POLR2A IQSEC2 PITX1 SMARCA4 SMARCC2 ZMIZ1 ARID1A FOXA2 CREBBP | 5.11e-05 | 772 | 27 | 13 | HP:0007370 |
| HumanPheno | Language impairment | TCF4 ARID1B MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 5.67e-05 | 1178 | 27 | 16 | HP:0002463 |
| HumanPheno | Thick lower lip vermilion | 6.05e-05 | 136 | 27 | 6 | HP:0000179 | |
| HumanPheno | Abnormal cerebral ventricle morphology | TCF4 SEC24D ARID1B ERCC6 KIF26A POLR2A IQSEC2 PITX1 NPAP1 SMARCA4 SMARCC2 TAOK1 ZMIZ1 ARID1A CREBBP | 6.28e-05 | 1046 | 27 | 15 | HP:0002118 |
| HumanPheno | Anteverted nares | TCF4 ARID1B CSNK2A1 IQSEC2 SMARCA2 SMARCA4 AUTS2 SMARCC2 LTBP3 ARID1A CREBBP | 6.33e-05 | 559 | 27 | 11 | HP:0000463 |
| HumanPheno | Upturned nose | TCF4 ARID1B CSNK2A1 IQSEC2 SMARCA2 SMARCA4 AUTS2 SMARCC2 LTBP3 ARID1A CREBBP | 6.33e-05 | 559 | 27 | 11 | HP:0000427 |
| HumanPheno | Abnormal external nose morphology | TCF4 ARID1B CSNK2A1 IQSEC2 SMARCA2 SMARCA4 AUTS2 SMARCC2 LTBP3 ZMIZ1 ARID1A FOXA2 SRRM2 CREBBP | 6.56e-05 | 916 | 27 | 14 | HP:0010938 |
| HumanPheno | Ventriculomegaly | TCF4 ARID1B ERCC6 KIF26A POLR2A IQSEC2 PITX1 NPAP1 SMARCA4 SMARCC2 TAOK1 ZMIZ1 ARID1A | 6.56e-05 | 790 | 27 | 13 | HP:0002119 |
| HumanPheno | Simplified gyral pattern | 6.56e-05 | 84 | 27 | 5 | HP:0009879 | |
| HumanPheno | Agenesis of corpus callosum | ARID1B ERCC6 KIF26A POLR2A SMARCA4 SMARCC2 ARID1A FOXA2 CREBBP | 6.63e-05 | 365 | 27 | 9 | HP:0001274 |
| HumanPheno | Aplasia/hypoplasia involving the skeleton | TCF4 SEC24D ARID1B ERCC6 KIF26A CSNK2A1 IQSEC2 PITX1 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 LTBP3 ZMIZ1 ARID1A CREBBP | 6.71e-05 | 1343 | 27 | 17 | HP:0009115 |
| HumanPheno | Abnormal eyebrow morphology | TCF4 ARID1B KIF26A CSNK2A1 IQSEC2 SMARCA2 SMARCA4 AUTS2 SMARCC2 LTBP3 ARID1A CREBBP | 6.79e-05 | 674 | 27 | 12 | HP:0000534 |
| HumanPheno | Abnormal conjugate eye movement | TCF4 ARID1B ERCC6 MAPT POLR2A IQSEC2 NPAP1 SMARCA4 AUTS2 SMARCC2 GRIA1 TAOK1 ZMIZ1 ARID1A SRRM2 CREBBP | 7.06e-05 | 1198 | 27 | 16 | HP:0000549 |
| HumanPheno | Neoplasm of the liver | 7.12e-05 | 140 | 27 | 6 | HP:0002896 | |
| HumanPheno | Intellectual disability, severe | TCF4 ARID1B IQSEC2 SMARCA2 SMARCA4 SMARCC2 GRIA1 ARID1A CTSD | 7.54e-05 | 371 | 27 | 9 | HP:0010864 |
| HumanPheno | Aplasia/hypoplasia involving bones of the upper limbs | TCF4 ARID1B PITX1 NPAP1 SMARCA2 SMARCA4 SMARCC2 LTBP3 ZMIZ1 ARID1A CREBBP | 7.84e-05 | 572 | 27 | 11 | HP:0006496 |
| HumanPheno | Self-injurious behavior | 8.04e-05 | 210 | 27 | 7 | HP:0100716 | |
| HumanPheno | Short phalanx of the 5th toe | 8.09e-05 | 3 | 27 | 2 | HP:0100368 | |
| HumanPheno | Abnormal nostril morphology | TCF4 ARID1B CSNK2A1 IQSEC2 SMARCA2 SMARCA4 AUTS2 SMARCC2 LTBP3 ARID1A CREBBP | 8.23e-05 | 575 | 27 | 11 | HP:0005288 |
| HumanPheno | Abnormal corpus callosum morphology | TCF4 ARID1B ERCC6 KIF26A POLR2A IQSEC2 PITX1 SMARCA2 SMARCA4 SMARCC2 ZMIZ1 ARID1A FOXA2 CREBBP | 8.51e-05 | 937 | 27 | 14 | HP:0001273 |
| HumanPheno | Abnormal curvature of the vertebral column | TCF4 SEC24D ARID1B ERCC6 MAPT CSNK2A1 IQSEC2 NPAP1 SMARCA2 SMARCA4 AUTS2 SMARCC2 LTBP3 ZMIZ1 ARID1A CREBBP | 8.84e-05 | 1219 | 27 | 16 | HP:0010674 |
| HumanPheno | Low anterior hairline | 9.35e-05 | 147 | 27 | 6 | HP:0000294 | |
| HumanPheno | Hirsutism | 9.61e-05 | 216 | 27 | 7 | HP:0001007 | |
| HumanPheno | Unusual infection | TCF4 ARID1B ERCC6 POLR2A IQSEC2 TBX21 NPAP1 SMARCA2 SMARCA4 SMARCC2 GRIA1 SMARCD2 TAOK1 ARID1A CREBBP | 1.02e-04 | 1088 | 27 | 15 | HP:0032101 |
| HumanPheno | Abnormal nasal tip morphology | TCF4 ARID1B SMARCA2 SMARCA4 AUTS2 SMARCC2 LTBP3 ARID1A SRRM2 | 1.03e-04 | 386 | 27 | 9 | HP:0000436 |
| HumanPheno | Hernia | TCF4 ARID1B CSNK2A1 POLR2A SMARCA2 SMARCA4 AUTS2 SMARCC2 PLD1 ARID1A CREBBP | 1.03e-04 | 589 | 27 | 11 | HP:0100790 |
| HumanPheno | Abnormal posterior cranial fossa morphology | 1.11e-04 | 221 | 27 | 7 | HP:0000932 | |
| HumanPheno | Sleep abnormality | TCF4 ERCC6 MAPT CSNK2A1 POLR2A IQSEC2 NPAP1 SMARCC2 GRIA1 LTBP3 CREBBP | 1.15e-04 | 596 | 27 | 11 | HP:0002360 |
| HumanPheno | Dysplastic corpus callosum | ARID1B ERCC6 KIF26A POLR2A SMARCA4 SMARCC2 ARID1A FOXA2 CREBBP | 1.23e-04 | 395 | 27 | 9 | HP:0006989 |
| HumanPheno | Sandal gap | 1.24e-04 | 96 | 27 | 5 | HP:0001852 | |
| HumanPheno | Prominent lips | 1.30e-04 | 156 | 27 | 6 | HP:0000184 | |
| HumanPheno | Abnormal cerebral white matter morphology | TCF4 ARID1B ERCC6 KIF26A MAPT POLR2A IQSEC2 PITX1 SMARCA2 SMARCA4 SMARCC2 ZMIZ1 ARID1A FOXA2 CREBBP | 1.35e-04 | 1114 | 27 | 15 | HP:0002500 |
| MousePheno | impaired cued conditioning behavior | 1.55e-05 | 82 | 54 | 5 | MP:0009456 | |
| MousePheno | abnormal forebrain morphology | TCF4 NCOA6 ARID1B MAPT CSNK2A1 ITSN1 IQSEC2 PITX1 TAOK1 SYNPO SSBP3 ARID1A CTSD CREBBP | 3.96e-05 | 1072 | 54 | 14 | MP:0000783 |
| MousePheno | impaired conditioning behavior | 3.99e-05 | 165 | 54 | 6 | MP:0012317 | |
| MousePheno | abnormal social investigation | 4.87e-05 | 171 | 54 | 6 | MP:0001360 | |
| MousePheno | abnormal postnatal growth | JUND ARID1B ERCC6 KIF26A MAPT ITSN1 POLR2A IQSEC2 PITX1 LTBP3 FOXA2 CREBBP | 1.40e-04 | 907 | 54 | 12 | MP:0001731 |
| MousePheno | stereotypic behavior | 1.68e-04 | 214 | 54 | 6 | MP:0001408 | |
| MousePheno | abnormal grooming behavior | 1.81e-04 | 137 | 54 | 5 | MP:0001440 | |
| MousePheno | decreased susceptibility to induction of seizure by inducing agent | 1.85e-04 | 29 | 54 | 3 | MP:0012348 | |
| MousePheno | decreased susceptibility to pharmacologically induced seizures | 1.85e-04 | 29 | 54 | 3 | MP:0002887 | |
| MousePheno | increased grooming behavior | 1.87e-04 | 74 | 54 | 4 | MP:0001441 | |
| MousePheno | abnormal social/conspecific interaction behavior | 1.95e-04 | 421 | 54 | 8 | MP:0002557 | |
| MousePheno | abnormal nervous system development | TCF4 NCOA6 ARID1B KIF26A MAPT CSNK2A1 IQSEC2 SMARCA4 AUTS2 SYNPO SSBP3 ARID1A FOXA2 CREBBP | 2.20e-04 | 1257 | 54 | 14 | MP:0003861 |
| MousePheno | abnormal telencephalon morphology | TCF4 NCOA6 ARID1B MAPT CSNK2A1 ITSN1 IQSEC2 TAOK1 SYNPO SSBP3 CTSD | 2.28e-04 | 812 | 54 | 11 | MP:0000787 |
| MousePheno | lethality, complete penetrance | 2.74e-04 | 33 | 54 | 3 | MP:0011400 | |
| MousePheno | hindlimb oligodactyly | 3.04e-04 | 7 | 54 | 2 | MP:0014281 | |
| MousePheno | abnormal temporal memory | 3.05e-04 | 239 | 54 | 6 | MP:0001468 | |
| MousePheno | abnormal dentate gyrus morphology | 3.34e-04 | 86 | 54 | 4 | MP:0000812 | |
| MousePheno | abnormal cued conditioning behavior | 3.82e-04 | 161 | 54 | 5 | MP:0001454 | |
| MousePheno | decreased social investigation | 4.18e-04 | 38 | 54 | 3 | MP:0021111 | |
| MousePheno | embryonic lethality during organogenesis | NCOA6 SEC24D CSNK2A1 PITX1 SMARCA4 SMARCD3 ZMIZ1 SSBP3 ARID1A FOXA2 CREBBP | 4.37e-04 | 876 | 54 | 11 | MP:0006207 |
| MousePheno | oligodactyly | 4.51e-04 | 39 | 54 | 3 | MP:0000565 | |
| MousePheno | postnatal growth retardation | JUND ARID1B ERCC6 KIF26A MAPT ITSN1 POLR2A IQSEC2 LTBP3 FOXA2 CREBBP | 4.59e-04 | 881 | 54 | 11 | MP:0001732 |
| MousePheno | abnormal anxiety-related response | TCF4 ARID1B MAPT IQSEC2 AUTS2 SMARCC2 GRIA1 SYNPO PSPC1 CREBBP | 4.67e-04 | 740 | 54 | 10 | MP:0001362 |
| MousePheno | abnormal sexual interaction | 4.69e-04 | 94 | 54 | 4 | MP:0002566 | |
| MousePheno | enlarged hippocampus | 5.18e-04 | 9 | 54 | 2 | MP:0008282 | |
| MousePheno | abnormal long-term spatial reference memory | 5.24e-04 | 41 | 54 | 3 | MP:0008432 | |
| MousePheno | abnormal limbic system morphology | 5.92e-04 | 378 | 54 | 7 | MP:0004166 | |
| MousePheno | impaired contextual conditioning behavior | 6.15e-04 | 101 | 54 | 4 | MP:0009454 | |
| MousePheno | abnormal long-term object recognition memory | 6.45e-04 | 44 | 54 | 3 | MP:0002801 | |
| MousePheno | decreased exploration in new environment | 7.05e-04 | 510 | 54 | 8 | MP:0001417 | |
| MousePheno | decreased vocalization | 7.35e-04 | 46 | 54 | 3 | MP:0020351 | |
| MousePheno | thin myocardium compact layer | 7.35e-04 | 46 | 54 | 3 | MP:0004057 | |
| MousePheno | abnormal response to novelty | ARID1B SH3RF1 MAPT ZMIZ2 ITSN1 IQSEC2 AUTS2 GRIA1 TAOK1 PSPC1 | 7.56e-04 | 787 | 54 | 10 | MP:0003107 |
| MousePheno | abnormal exploration in a new environment | 7.56e-04 | 647 | 54 | 9 | MP:0013189 | |
| MousePheno | abnormal response to social novelty | 8.85e-04 | 49 | 54 | 3 | MP:0020395 | |
| Domain | SnAC | 1.08e-05 | 2 | 62 | 2 | SM01314 | |
| Domain | BAF250_C | 1.08e-05 | 2 | 62 | 2 | IPR033388 | |
| Domain | Gln-Leu-Gln_QLQ | 1.08e-05 | 2 | 62 | 2 | IPR014978 | |
| Domain | SnAC | 1.08e-05 | 2 | 62 | 2 | IPR029295 | |
| Domain | SnAC | 1.08e-05 | 2 | 62 | 2 | PF14619 | |
| Domain | QLQ | 1.08e-05 | 2 | 62 | 2 | SM00951 | |
| Domain | BAF250_C | 1.08e-05 | 2 | 62 | 2 | PF12031 | |
| Domain | QLQ | 1.08e-05 | 2 | 62 | 2 | PS51666 | |
| Domain | BAF250/Osa | 1.08e-05 | 2 | 62 | 2 | IPR021906 | |
| Domain | QLQ | 1.08e-05 | 2 | 62 | 2 | PF08880 | |
| Domain | SSDP_DNA-bd | 3.25e-05 | 3 | 62 | 2 | IPR008116 | |
| Domain | SWIB_domain | 3.25e-05 | 3 | 62 | 2 | IPR019835 | |
| Domain | SWIB | 3.25e-05 | 3 | 62 | 2 | SM00151 | |
| Domain | HSA | 6.48e-05 | 4 | 62 | 2 | SM00573 | |
| Domain | HSA | 6.48e-05 | 4 | 62 | 2 | PS51204 | |
| Domain | HSA_dom | 6.48e-05 | 4 | 62 | 2 | IPR014012 | |
| Domain | HSA | 6.48e-05 | 4 | 62 | 2 | PF07529 | |
| Domain | Bromodomain_CS | 8.58e-05 | 26 | 62 | 3 | IPR018359 | |
| Domain | SWIB | 1.08e-04 | 5 | 62 | 2 | PF02201 | |
| Domain | BRK | 1.61e-04 | 6 | 62 | 2 | SM00592 | |
| Domain | BRK_domain | 1.61e-04 | 6 | 62 | 2 | IPR006576 | |
| Domain | SWIB_MDM2_domain | 1.61e-04 | 6 | 62 | 2 | IPR003121 | |
| Domain | BRK | 1.61e-04 | 6 | 62 | 2 | PF07533 | |
| Domain | - | 1.61e-04 | 6 | 62 | 2 | 1.10.245.10 | |
| Domain | SNF2_N | 1.61e-04 | 32 | 62 | 3 | IPR000330 | |
| Domain | SNF2_N | 1.61e-04 | 32 | 62 | 3 | PF00176 | |
| Domain | zf-MIZ | 2.25e-04 | 7 | 62 | 2 | PF02891 | |
| Domain | ZF_SP_RING | 2.25e-04 | 7 | 62 | 2 | PS51044 | |
| Domain | BROMODOMAIN_1 | 2.50e-04 | 37 | 62 | 3 | PS00633 | |
| Domain | Bromodomain | 2.71e-04 | 38 | 62 | 3 | PF00439 | |
| Domain | Znf_MIZ | 3.00e-04 | 8 | 62 | 2 | IPR004181 | |
| Domain | BROMODOMAIN_2 | 3.39e-04 | 41 | 62 | 3 | PS50014 | |
| Domain | BROMO | 3.65e-04 | 42 | 62 | 3 | SM00297 | |
| Domain | Bromodomain | 3.65e-04 | 42 | 62 | 3 | IPR001487 | |
| Domain | - | 3.65e-04 | 42 | 62 | 3 | 1.20.920.10 | |
| Domain | - | 1.11e-03 | 15 | 62 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.11e-03 | 15 | 62 | 2 | SM00501 | |
| Domain | ARID_dom | 1.11e-03 | 15 | 62 | 2 | IPR001606 | |
| Domain | ARID | 1.11e-03 | 15 | 62 | 2 | PS51011 | |
| Domain | ARID | 1.11e-03 | 15 | 62 | 2 | PF01388 | |
| Domain | PH | 2.28e-03 | 278 | 62 | 5 | SM00233 | |
| Domain | PH_DOMAIN | 2.32e-03 | 279 | 62 | 5 | PS50003 | |
| Domain | PH_domain | 2.35e-03 | 280 | 62 | 5 | IPR001849 | |
| Domain | LisH | 3.88e-03 | 28 | 62 | 2 | SM00667 | |
| Domain | LisH | 3.88e-03 | 28 | 62 | 2 | IPR006594 | |
| Domain | LISH | 3.88e-03 | 28 | 62 | 2 | PS50896 | |
| Domain | Helicase_C | 5.41e-03 | 107 | 62 | 3 | PF00271 | |
| Domain | HELICc | 5.41e-03 | 107 | 62 | 3 | SM00490 | |
| Domain | Helicase_C | 5.55e-03 | 108 | 62 | 3 | IPR001650 | |
| Domain | HELICASE_CTER | 5.70e-03 | 109 | 62 | 3 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.70e-03 | 109 | 62 | 3 | PS51192 | |
| Domain | DEXDc | 5.70e-03 | 109 | 62 | 3 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.84e-03 | 110 | 62 | 3 | IPR014001 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | ARID1B CSNK2A1 SMARCA2 SMARCA4 AUTS2 SMARCC2 SMARCD2 SMARCD3 ARID1A | 1.01e-14 | 37 | 54 | 9 | M27797 |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.09e-13 | 29 | 54 | 8 | M48076 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 4.02e-11 | 34 | 54 | 7 | MM15531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 5.01e-11 | 35 | 54 | 7 | M47969 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 1.97e-10 | 42 | 54 | 7 | M48237 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.62e-09 | 31 | 54 | 6 | M39522 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 1.73e-08 | 78 | 54 | 7 | M27234 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | ARID1B CSNK2A1 SMARCA2 SMARCA4 AUTS2 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 1.87e-08 | 237 | 54 | 10 | M27786 |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 4.63e-08 | 137 | 54 | 8 | M48232 |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 6.90e-08 | 95 | 54 | 7 | M48268 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 7.98e-08 | 97 | 54 | 7 | M48262 | |
| Pathway | WP_THERMOGENESIS | 1.68e-07 | 108 | 54 | 7 | M39746 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 4.06e-07 | 40 | 54 | 5 | MM14936 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | NCOA6 ARID1B ERCC6 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A | 4.55e-07 | 254 | 54 | 9 | M27131 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | MED15 TCF4 NCOA6 ARID1B MED30 CSNK2A1 ITSN1 POLR2A MED14 SMARCA2 SMARCA4 ARHGEF12 SMARCC2 SMARCD2 SMARCD3 ARID1A FOXA2 CREBBP MAML3 | 6.76e-07 | 1432 | 54 | 19 | M509 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 7.68e-07 | 84 | 54 | 6 | M1008 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 1.08e-06 | 142 | 54 | 7 | M48257 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.79e-06 | 153 | 54 | 7 | MM15522 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.93e-06 | 24 | 54 | 4 | M13404 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 3.75e-06 | 110 | 54 | 6 | M48043 | |
| Pathway | REACTOME_ADIPOGENESIS | 3.75e-06 | 110 | 54 | 6 | M48259 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 5.63e-06 | 118 | 54 | 6 | M27316 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 8.36e-06 | 272 | 54 | 8 | M29619 |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 1.14e-05 | 12 | 54 | 3 | M22006 | |
| Pathway | WP_RETT_SYNDROME | 3.30e-05 | 48 | 54 | 4 | M39759 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | MED15 ARID1B MED30 HDAC5 CSNK2A1 POLR2A MED14 SMARCA2 SMARCA4 AUTS2 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP MAML3 | 3.99e-05 | 1387 | 54 | 16 | M734 |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 4.16e-05 | 18 | 54 | 3 | M26942 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 5.67e-05 | 55 | 54 | 4 | M27001 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 7.77e-05 | 22 | 54 | 3 | MM1370 | |
| Pathway | PID_AR_PATHWAY | 8.54e-05 | 61 | 54 | 4 | M58 | |
| Pathway | REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY | 9.32e-05 | 120 | 54 | 5 | M48233 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 1.09e-04 | 65 | 54 | 4 | M39682 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.30e-04 | 26 | 54 | 3 | M2499 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 1.46e-04 | 27 | 54 | 3 | M26943 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.63e-04 | 28 | 54 | 3 | M6177 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.14e-04 | 6 | 54 | 2 | M22062 | |
| Pathway | PID_REG_GR_PATHWAY | 2.70e-04 | 82 | 54 | 4 | M115 | |
| Pathway | REACTOME_RSV_HOST_INTERACTIONS | 5.32e-04 | 98 | 54 | 4 | M48247 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 5.38e-04 | 175 | 54 | 5 | MM14941 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 5.49e-04 | 42 | 54 | 3 | M17541 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 5.49e-04 | 42 | 54 | 3 | M27172 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | HDAC5 CSNK2A1 POLR2A SMARCA4 AUTS2 SMARCC2 SMARCD2 SMARCD3 ARID1A MAML3 | 5.85e-04 | 768 | 54 | 10 | MM14851 |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 6.35e-04 | 10 | 54 | 2 | MM1532 | |
| Pathway | PID_LKB1_PATHWAY | 7.65e-04 | 47 | 54 | 3 | M87 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 8.14e-04 | 48 | 54 | 3 | M611 | |
| Pathway | REACTOME_HEME_SIGNALING | 8.64e-04 | 49 | 54 | 3 | M41832 | |
| Pathway | KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2 | 9.27e-04 | 12 | 54 | 2 | M47943 | |
| Pathway | PID_AR_TF_PATHWAY | 1.09e-03 | 53 | 54 | 3 | M151 | |
| Pathway | KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT | 1.09e-03 | 13 | 54 | 2 | M47763 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 1.21e-03 | 55 | 54 | 3 | M27145 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 1.27e-03 | 14 | 54 | 2 | M27808 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 1.41e-03 | 58 | 54 | 3 | M29616 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | ERCC6 HDAC5 CSNK2A1 POLR2A SMARCA4 AUTS2 SMARCC2 SMARCD2 SMARCD3 ARID1A MAML3 | 1.46e-03 | 1022 | 54 | 11 | MM15436 |
| Pathway | WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME | 1.53e-03 | 130 | 54 | 4 | M39787 | |
| Pathway | REACTOME_CYTOPROTECTION_BY_HMOX1 | 1.56e-03 | 60 | 54 | 3 | M41830 | |
| Pathway | WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME | 1.63e-03 | 61 | 54 | 3 | M48077 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 1.67e-03 | 16 | 54 | 2 | M27121 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 2.14e-03 | 757 | 54 | 9 | M27451 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 2.43e-03 | 70 | 54 | 3 | M938 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 2.52e-03 | 149 | 54 | 4 | M27888 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.62e-03 | 20 | 54 | 2 | M27881 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 2.83e-03 | 154 | 54 | 4 | M27832 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 2.84e-03 | 74 | 54 | 3 | M616 | |
| Pathway | WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX | 2.89e-03 | 21 | 54 | 2 | M39593 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 2.90e-03 | 155 | 54 | 4 | M41808 | |
| Pathway | WP_ESTROGEN_SIGNALING | 3.18e-03 | 77 | 54 | 3 | MM15934 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 3.46e-03 | 23 | 54 | 2 | MM1527 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.46e-03 | 23 | 54 | 2 | MM14954 | |
| Pathway | BIOCARTA_WNT_PATHWAY | 3.77e-03 | 24 | 54 | 2 | M16517 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.08e-03 | 25 | 54 | 2 | M27880 | |
| Pubmed | MED15 TCF4 NCOA6 JUND ARID1B CDC42BPA HDAC5 IRF2BP1 CSNK2A1 ZMIZ2 PITX1 SMARCA2 SMARCA4 AUTS2 SMARCC2 DIDO1 SMARCD2 SMARCD3 ZMIZ1 PAN3 SSBP4 SSBP3 ARID1A SRRM2 CREBBP INO80D | 1.55e-19 | 1429 | 65 | 26 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | MED15 NCOA6 ARID1B HDAC5 ZMIZ2 PITX1 SMARCA2 SMARCA4 AUTS2 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A CREBBP | 1.12e-16 | 351 | 65 | 15 | 38297188 |
| Pubmed | NCOA6 ARID1B HDAC5 CSNK2A1 SMARCA2 SMARCA4 AUTS2 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 1.53e-16 | 157 | 65 | 12 | 30186101 | |
| Pubmed | Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. | 1.94e-16 | 14 | 65 | 7 | 8895581 | |
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 3.63e-16 | 15 | 65 | 7 | 11175787 | |
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 3.63e-16 | 15 | 65 | 7 | 17920018 | |
| Pubmed | 3.63e-16 | 15 | 65 | 7 | 11263494 | ||
| Pubmed | BAF complexes facilitate decatenation of DNA by topoisomerase IIα. | 1.79e-15 | 18 | 65 | 7 | 23698369 | |
| Pubmed | 2.82e-15 | 19 | 65 | 7 | 16932743 | ||
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 2.82e-15 | 19 | 65 | 7 | 12110891 | |
| Pubmed | MED15 NCOA6 JUND ARID1B IRF2BP1 CSNK2A1 ZMIZ2 PITX1 MED14 SMARCA2 SMARCA4 SMARCC2 DIDO1 SMARCD2 ARID1A SRRM2 IFI16 PSPC1 CREBBP INO80D | 6.55e-15 | 1103 | 65 | 20 | 34189442 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 1.37e-14 | 23 | 65 | 7 | 30962207 | |
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 1.37e-14 | 23 | 65 | 7 | 8804307 | |
| Pubmed | 1.93e-14 | 24 | 65 | 7 | 11790558 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 1.93e-14 | 24 | 65 | 7 | 10078207 | |
| Pubmed | 1.93e-14 | 24 | 65 | 7 | 12215535 | ||
| Pubmed | 3.65e-14 | 26 | 65 | 7 | 10778858 | ||
| Pubmed | 4.92e-14 | 27 | 65 | 7 | 29374058 | ||
| Pubmed | 5.71e-14 | 13 | 65 | 6 | 17340523 | ||
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 6.55e-14 | 28 | 65 | 7 | 12192000 | |
| Pubmed | 8.62e-14 | 29 | 65 | 7 | 19279220 | ||
| Pubmed | 1.17e-13 | 6 | 65 | 5 | 16230384 | ||
| Pubmed | 1.66e-13 | 15 | 65 | 6 | 23785148 | ||
| Pubmed | 3.68e-13 | 35 | 65 | 7 | 32504627 | ||
| Pubmed | 4.09e-13 | 17 | 65 | 6 | 11078522 | ||
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 4.09e-13 | 17 | 65 | 6 | 12368262 | |
| Pubmed | 5.02e-13 | 66 | 65 | 8 | 23275444 | ||
| Pubmed | 5.62e-13 | 37 | 65 | 7 | 24335282 | ||
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 1.01e-12 | 40 | 65 | 7 | 34585037 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | MED15 NCOA6 JUND ARID1B IRF2BP1 SMARCA2 AUTS2 ZMIZ1 ARID1A FOXA2 PSPC1 CREBBP MAML3 | 2.60e-12 | 457 | 65 | 13 | 32344865 |
| Pubmed | MED15 NCOA6 ARID1B CSNK2A1 MED14 SMARCA2 SMARCA4 SMARCC2 SMARCD2 ARID1A CREBBP | 2.87e-12 | 268 | 65 | 11 | 33640491 | |
| Pubmed | 1.08e-11 | 55 | 65 | 7 | 35945219 | ||
| Pubmed | 1.19e-11 | 152 | 65 | 9 | 38360978 | ||
| Pubmed | 1.53e-11 | 12 | 65 | 5 | 11734557 | ||
| Pubmed | 1.54e-11 | 29 | 65 | 6 | 36800290 | ||
| Pubmed | 1.93e-11 | 30 | 65 | 6 | 31043422 | ||
| Pubmed | 2.30e-11 | 61 | 65 | 7 | 20305087 | ||
| Pubmed | Fanconi anemia protein, FANCA, associates with BRG1, a component of the human SWI/SNF complex. | 2.48e-11 | 13 | 65 | 5 | 11726552 | |
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | MED15 MED30 SALL3 POLR2A MED14 SMARCA4 SMARCC2 SMARCD2 ARID1A | 2.77e-11 | 167 | 65 | 9 | 20362541 |
| Pubmed | 3.65e-11 | 65 | 65 | 7 | 26655900 | ||
| Pubmed | 5.55e-11 | 5 | 65 | 4 | 12200431 | ||
| Pubmed | 5.77e-11 | 15 | 65 | 5 | 17640523 | ||
| Pubmed | Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma. | 8.38e-11 | 16 | 65 | 5 | 35390516 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCOA6 JUND MAPT CSNK2A1 ITSN1 POLR2A MED14 SMARCA2 SMARCA4 SMARCC2 DIDO1 TAOK1 SRRM2 IFI16 | 1.39e-10 | 774 | 65 | 14 | 15302935 |
| Pubmed | 1.64e-10 | 18 | 65 | 5 | 14559996 | ||
| Pubmed | 1.66e-10 | 6 | 65 | 4 | 16940996 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 1.66e-10 | 6 | 65 | 4 | 25081545 | |
| Pubmed | ARID1B ERCC6 MAPT CSNK2A1 POLR2A RTL9 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 PLD1 ARID1A SRRM2 CREBBP INO80D | 1.68e-10 | 1116 | 65 | 16 | 31753913 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | SALL3 CDC42BPA CSNK2A1 TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 ARID1A SRRM2 PSPC1 | 2.78e-10 | 411 | 65 | 11 | 35182466 |
| Pubmed | 2.96e-10 | 20 | 65 | 5 | 9128241 | ||
| Pubmed | 3.87e-10 | 7 | 65 | 4 | 28369036 | ||
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 4.07e-10 | 150 | 65 | 8 | 28242625 | |
| Pubmed | TCF4 JUND SH3RF1 ZNF358 ZMIZ2 TBX21 SMARCA2 SMARCA4 DIDO1 SMARCD2 ARID1A CREBBP MAML3 | 5.84e-10 | 709 | 65 | 13 | 22988430 | |
| Pubmed | 7.42e-10 | 99 | 65 | 7 | 34161765 | ||
| Pubmed | MED15 ARID1B MED30 MED14 SMARCC2 SMARCD2 SMARCD3 ARID1A IFI16 PSPC1 CREBBP | 7.72e-10 | 453 | 65 | 11 | 29656893 | |
| Pubmed | 7.73e-10 | 8 | 65 | 4 | 26986003 | ||
| Pubmed | 1.39e-09 | 9 | 65 | 4 | 23556151 | ||
| Pubmed | 1.39e-09 | 9 | 65 | 4 | 37805104 | ||
| Pubmed | 1.39e-09 | 9 | 65 | 4 | 9845365 | ||
| Pubmed | Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. | 1.39e-09 | 9 | 65 | 4 | 20086098 | |
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 1.58e-09 | 178 | 65 | 8 | 27637333 | |
| Pubmed | 1.85e-09 | 28 | 65 | 5 | 30037996 | ||
| Pubmed | 2.31e-09 | 10 | 65 | 4 | 12665591 | ||
| Pubmed | 2.31e-09 | 10 | 65 | 4 | 34716243 | ||
| Pubmed | Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. | 2.31e-09 | 10 | 65 | 4 | 16751102 | |
| Pubmed | Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes. | 2.31e-09 | 10 | 65 | 4 | 11238380 | |
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 2.31e-09 | 10 | 65 | 4 | 23129809 | |
| Pubmed | Placing the HIRA histone chaperone complex in the chromatin landscape. | 3.19e-09 | 31 | 65 | 5 | 23602572 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | MED15 ARID1B ZMIZ2 SMARCA2 SMARCA4 AUTS2 SMARCC2 SMARCD2 ARID1A CREBBP | 3.52e-09 | 398 | 65 | 10 | 35016035 |
| Pubmed | 3.63e-09 | 11 | 65 | 4 | 18003620 | ||
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 3.68e-09 | 69 | 65 | 6 | 28481362 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | MED15 MED30 PELP1 POLR2A MED14 SMARCA2 SMARCA4 SMARCC2 SMARCD2 ARID1A SRRM2 | 4.19e-09 | 533 | 65 | 11 | 30554943 |
| Pubmed | MED15 MED30 IRF2BP1 CSNK2A1 POLR2A MED14 SMARCA2 SMARCA4 SMARCC2 DIDO1 SMARCD2 IFI16 PSPC1 CREBBP | 4.49e-09 | 1014 | 65 | 14 | 32416067 | |
| Pubmed | 5.20e-09 | 34 | 65 | 5 | 15989967 | ||
| Pubmed | 5.44e-09 | 12 | 65 | 4 | 33723076 | ||
| Pubmed | 6.23e-09 | 3 | 65 | 3 | 36464671 | ||
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 6.23e-09 | 3 | 65 | 3 | 22426308 | |
| Pubmed | 7.78e-09 | 78 | 65 | 6 | 28611094 | ||
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 1.10e-08 | 14 | 65 | 4 | 36289231 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.49e-08 | 341 | 65 | 9 | 32971831 | |
| Pubmed | 1.49e-08 | 15 | 65 | 4 | 15985610 | ||
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 1.49e-08 | 15 | 65 | 4 | 17255939 | |
| Pubmed | 1.62e-08 | 88 | 65 | 6 | 26318153 | ||
| Pubmed | NCOA6 ARID1B ITSN1 POLR2A SMARCA2 DIDO1 ARID1A SRRM2 CTSD PSPC1 | 1.77e-08 | 472 | 65 | 10 | 38943005 | |
| Pubmed | A human RNA polymerase II complex containing factors that modify chromatin structure. | 1.99e-08 | 16 | 65 | 4 | 9710619 | |
| Pubmed | 1.99e-08 | 246 | 65 | 8 | 15345747 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 22621927 | ||
| Pubmed | Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. | 2.49e-08 | 4 | 65 | 3 | 11988099 | |
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 33481850 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 31906887 | ||
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 28863077 | ||
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 2.49e-08 | 4 | 65 | 3 | 15170388 | |
| Pubmed | 2.49e-08 | 4 | 65 | 3 | 17878164 | ||
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 3.33e-08 | 18 | 65 | 4 | 28068325 | |
| Pubmed | Misregulation of Alternative Splicing in a Mouse Model of Rett Syndrome. | 3.49e-08 | 49 | 65 | 5 | 27352031 | |
| Pubmed | Regulation of the CUL3Â Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 3.87e-08 | 50 | 65 | 5 | 27716508 | |
| Pubmed | 4.22e-08 | 19 | 65 | 4 | 25066234 | ||
| Pubmed | 4.22e-08 | 19 | 65 | 4 | 18809673 | ||
| Pubmed | ATAC and Mediator coactivators form a stable complex and regulate a set of non-coding RNA genes. | 5.25e-08 | 107 | 65 | 6 | 20508642 | |
| Pubmed | 5.26e-08 | 20 | 65 | 4 | 34220450 | ||
| Interaction | SS18L1 interactions | ARID1B MED30 ZMIZ2 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 SSBP3 ARID1A CREBBP | 1.21e-14 | 98 | 64 | 11 | int:SS18L1 |
| Interaction | DDIT3 interactions | JUND ARID1B HDAC5 CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 1.19e-13 | 120 | 64 | 11 | int:DDIT3 |
| Interaction | SP7 interactions | NCOA6 ARID1B IRF2BP1 ZMIZ2 PITX1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 SSBP3 ARID1A CREBBP | 5.70e-13 | 304 | 64 | 14 | int:SP7 |
| Interaction | HNF4A interactions | NCOA6 ARID1B HDAC5 IRF2BP1 MED14 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A FOXA2 CREBBP | 3.03e-12 | 275 | 64 | 13 | int:HNF4A |
| Interaction | BRD9 interactions | ARID1B CSNK2A1 MED14 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A SRRM2 | 3.42e-12 | 117 | 64 | 10 | int:BRD9 |
| Interaction | SMARCC2 interactions | TCF4 ARID1B CSNK2A1 ITSN1 POLR2A SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 SSBP3 ARID1A IFI16 CREBBP | 4.29e-12 | 353 | 64 | 14 | int:SMARCC2 |
| Interaction | IRF1 interactions | ARID1B CSNK2A1 POLR2A SMARCA2 SMARCA4 SMARCD2 SMARCD3 ARID1A CREBBP | 5.00e-12 | 83 | 64 | 9 | int:IRF1 |
| Interaction | CIITA interactions | 7.12e-12 | 55 | 64 | 8 | int:CIITA | |
| Interaction | TLE3 interactions | MED15 TCF4 JUND ARID1B ZMIZ2 SMARCA4 AUTS2 SMARCC2 ZMIZ1 SSBP4 ARID1A SRRM2 CREBBP INO80D | 1.00e-11 | 376 | 64 | 14 | int:TLE3 |
| Interaction | SMARCA4 interactions | ARID1B ERCC6 CSNK2A1 ZMIZ2 POLR2A TBX21 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 SSBP3 ARID1A SRRM2 CREBBP | 1.16e-11 | 462 | 64 | 15 | int:SMARCA4 |
| Interaction | DPF3 interactions | ARID1B MAPT CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A | 1.74e-11 | 95 | 64 | 9 | int:DPF3 |
| Interaction | SOX9 interactions | NCOA6 ARID1B HDAC5 SMARCA2 SMARCA4 SMARCC2 SMARCD2 ARID1A CREBBP | 2.10e-11 | 97 | 64 | 9 | int:SOX9 |
| Interaction | NUP35 interactions | MED15 NCOA6 JUND ARID1B IRF2BP1 SMARCA2 AUTS2 ZMIZ1 ARID1A FOXA2 IFI16 PSPC1 CREBBP MAML3 | 4.94e-11 | 424 | 64 | 14 | int:NUP35 |
| Interaction | SMARCA2 interactions | ARID1B ERCC6 MAPT POLR2A PITX1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A SRRM2 CREBBP | 5.37e-11 | 346 | 64 | 13 | int:SMARCA2 |
| Interaction | ACTL6A interactions | MED15 TCF4 ARID1B POLR2A MED14 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A INO80D | 1.02e-10 | 289 | 64 | 12 | int:ACTL6A |
| Interaction | TBXT interactions | NCOA6 ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SSBP3 ARID1A CREBBP | 1.07e-10 | 116 | 64 | 9 | int:TBXT |
| Interaction | CEBPA interactions | MED15 NCOA6 JUND ARID1B IRF2BP1 CSNK2A1 ZMIZ2 POLR2A PITX1 MED14 SMARCA2 SMARCA4 SMARCC2 DIDO1 SMARCD2 ARID1A SRRM2 IFI16 PSPC1 CREBBP INO80D | 1.09e-10 | 1245 | 64 | 21 | int:CEBPA |
| Interaction | AR interactions | MED15 TCF4 NCOA6 ARID1B CDC42BPA PELP1 CSNK2A1 ZMIZ2 MED14 SMARCA2 SMARCA4 SMARCC2 DIDO1 SMARCD2 ZMIZ1 ARID1A IFI16 PSPC1 CREBBP | 1.27e-10 | 992 | 64 | 19 | int:AR |
| Interaction | ETS1 interactions | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ZMIZ1 ARID1A CREBBP | 1.57e-10 | 121 | 64 | 9 | int:ETS1 |
| Interaction | SOX7 interactions | 1.95e-10 | 82 | 64 | 8 | int:SOX7 | |
| Interaction | PAX7 interactions | ARID1B CSNK2A1 SMARCA2 SMARCD2 SMARCD3 SSBP4 SSBP3 ARID1A CREBBP | 1.95e-10 | 124 | 64 | 9 | int:PAX7 |
| Interaction | RBBP4 interactions | MED15 ERCC6 SALL3 HDAC5 CSNK2A1 ITSN1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 ARID1A SRRM2 IFI16 CSNK2A3 CREBBP | 2.36e-10 | 573 | 64 | 15 | int:RBBP4 |
| Interaction | TPRX2 interactions | 4.77e-10 | 56 | 64 | 7 | int:TPRX2 | |
| Interaction | GATA2 interactions | NCOA6 ARID1B HDAC5 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SSBP3 ARID1A CREBBP | 6.70e-10 | 199 | 64 | 10 | int:GATA2 |
| Interaction | FLI1 interactions | 9.96e-10 | 62 | 64 | 7 | int:FLI1 | |
| Interaction | LHX1 interactions | 1.23e-09 | 103 | 64 | 8 | int:LHX1 | |
| Interaction | BICRA interactions | 1.74e-09 | 67 | 64 | 7 | int:BICRA | |
| Interaction | GCM1 interactions | 1.93e-09 | 68 | 64 | 7 | int:GCM1 | |
| Interaction | ERG interactions | NCOA6 ARID1B POLR2A SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 2.02e-09 | 223 | 64 | 10 | int:ERG |
| Interaction | ETV4 interactions | 2.15e-09 | 69 | 64 | 7 | int:ETV4 | |
| Interaction | NANOG interactions | TCF4 ARID1B SALL3 PELP1 CSNK2A1 POLR2A SMARCA2 SMARCA4 MUC16 DIDO1 ZMIZ1 SSBP3 ARID1A | 3.01e-09 | 481 | 64 | 13 | int:NANOG |
| Interaction | GATA1 interactions | ARID1B HDAC5 PITX1 MED14 SMARCA2 SMARCA4 SMARCC2 ARID1A CREBBP | 3.41e-09 | 171 | 64 | 9 | int:GATA1 |
| Interaction | FOS interactions | NCOA6 JUND ARID1B CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 3.68e-09 | 312 | 64 | 11 | int:FOS |
| Interaction | EPAS1 interactions | MED15 ARID1B POLR2A MED14 SMARCA2 SMARCA4 SMARCC2 SSBP3 CREBBP | 3.77e-09 | 173 | 64 | 9 | int:EPAS1 |
| Interaction | TEX13B interactions | 4.12e-09 | 20 | 64 | 5 | int:TEX13B | |
| Interaction | TLX1 interactions | ARID1B IRF2BP1 CSNK2A1 SMARCA2 AUTS2 SMARCD2 SSBP3 ARID1A CREBBP | 4.17e-09 | 175 | 64 | 9 | int:TLX1 |
| Interaction | SS18L2 interactions | 4.28e-09 | 76 | 64 | 7 | int:SS18L2 | |
| Interaction | EYA4 interactions | 4.62e-09 | 243 | 64 | 10 | int:EYA4 | |
| Interaction | MLLT1 interactions | ARID1B CSNK2A1 POLR2A SMARCA2 SMARCA4 SMARCC2 SMARCD2 ARID1A | 5.09e-09 | 123 | 64 | 8 | int:MLLT1 |
| Interaction | PAX9 interactions | 7.89e-09 | 130 | 64 | 8 | int:PAX9 | |
| Interaction | MYOD1 interactions | TCF4 ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 1.03e-08 | 194 | 64 | 9 | int:MYOD1 |
| Interaction | MTA2 interactions | MED30 ERCC6 HDAC5 CSNK2A1 POLR2A SMARCA2 SMARCA4 SMARCC2 SMARCD2 ARID1A SRRM2 CSNK2A3 | 1.05e-08 | 435 | 64 | 12 | int:MTA2 |
| Interaction | SS18 interactions | 1.21e-08 | 88 | 64 | 7 | int:SS18 | |
| Interaction | MEN1 interactions | NCOA6 JUND ARID1B ERCC6 CDC42BPA PELP1 CSNK2A1 POLR2A MED14 SMARCA4 SMARCC2 DIDO1 ARID1A SRRM2 IFI16 PSPC1 CSNK2A3 | 1.36e-08 | 1029 | 64 | 17 | int:MEN1 |
| Interaction | SMAD3 interactions | MED15 NCOA6 JUND ARID1B HDAC5 PITX1 SMARCA4 SMARCC2 ZMIZ1 ARID1A PSPC1 CREBBP | 1.42e-08 | 447 | 64 | 12 | int:SMAD3 |
| Interaction | BAZ1B interactions | ERCC6 POLR2A SMARCA2 SMARCA4 SMARCC2 SMARCD2 ARID1A SRRM2 IFI16 | 1.59e-08 | 204 | 64 | 9 | int:BAZ1B |
| Interaction | DPF1 interactions | 2.06e-08 | 95 | 64 | 7 | int:DPF1 | |
| Interaction | BCL7B interactions | 2.06e-08 | 95 | 64 | 7 | int:BCL7B | |
| Interaction | SMARCE1 interactions | TCF4 ARID1B ZMIZ2 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 SSBP3 ARID1A | 2.26e-08 | 287 | 64 | 10 | int:SMARCE1 |
| Interaction | SREBF1 interactions | 2.43e-08 | 150 | 64 | 8 | int:SREBF1 | |
| Interaction | JUN interactions | TCF4 NCOA6 JUND PELP1 CSNK2A1 SMARCA2 SMARCC2 DIDO1 SMARCD3 IFI16 PSPC1 CREBBP | 2.46e-08 | 470 | 64 | 12 | int:JUN |
| Interaction | RUVBL1 interactions | MED15 HDAC5 PELP1 MAPT CSNK2A1 ITSN1 SMARCA2 SMARCC2 SMARCD3 SSBP3 ARID1A CREBBP INO80D | 2.51e-08 | 575 | 64 | 13 | int:RUVBL1 |
| Interaction | SMARCC1 interactions | ARID1B POLR2A SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A SRRM2 IFI16 CREBBP | 3.14e-08 | 384 | 64 | 11 | int:SMARCC1 |
| Interaction | H2AX interactions | ARID1B PELP1 CSNK2A1 POLR2A SMARCA2 SMARCA4 SMARCC2 SMARCD2 ARID1A SRRM2 IFI16 CTSD CSNK2A3 | 3.61e-08 | 593 | 64 | 13 | int:H2AX |
| Interaction | MBD2 interactions | 4.22e-08 | 161 | 64 | 8 | int:MBD2 | |
| Interaction | SMARCD3 interactions | 4.72e-08 | 107 | 64 | 7 | int:SMARCD3 | |
| Interaction | LHX4 interactions | 5.35e-08 | 166 | 64 | 8 | int:LHX4 | |
| Interaction | NFATC1 interactions | 5.87e-08 | 168 | 64 | 8 | int:NFATC1 | |
| Interaction | PAX8 interactions | 6.09e-08 | 111 | 64 | 7 | int:PAX8 | |
| Interaction | EGR2 interactions | 6.74e-08 | 171 | 64 | 8 | int:EGR2 | |
| Interaction | MDC1 interactions | ARID1B CSNK2A1 POLR2A SMARCA4 SMARCC2 SMARCD2 SMARCD3 SSBP3 ARID1A IFI16 CREBBP | 6.74e-08 | 414 | 64 | 11 | int:MDC1 |
| Interaction | TBR1 interactions | 6.89e-08 | 113 | 64 | 7 | int:TBR1 | |
| Interaction | BCL7C interactions | 7.78e-08 | 115 | 64 | 7 | int:BCL7C | |
| Interaction | TEAD1 interactions | 8.42e-08 | 176 | 64 | 8 | int:TEAD1 | |
| Interaction | PPIA interactions | TCF4 NCOA6 ARID1B ERCC6 SALL3 HDAC5 ITSN1 POLR2A SMARCA2 DIDO1 SMARCD2 ARID1A SRRM2 CTSD PSPC1 | 8.60e-08 | 888 | 64 | 15 | int:PPIA |
| Interaction | ARID1B interactions | ARID1B SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 8.79e-08 | 177 | 64 | 8 | int:ARID1B |
| Interaction | TP53BP1 interactions | MED15 NCOA6 ARID1B MED30 PITX1 MED14 SMARCC2 SMARCD2 ARID1A IFI16 PSPC1 CREBBP | 9.73e-08 | 533 | 64 | 12 | int:TP53BP1 |
| Interaction | POLR2A interactions | MED30 ERCC6 CSNK2A1 POLR2A MED14 SMARCA2 SMARCA4 SMARCC2 DIDO1 IFI16 PSPC1 CREBBP | 1.03e-07 | 536 | 64 | 12 | int:POLR2A |
| Interaction | CRX interactions | MED15 ARID1B ZMIZ2 SMARCA2 SMARCD2 SMARCD3 ZMIZ1 ARID1A CREBBP | 1.05e-07 | 254 | 64 | 9 | int:CRX |
| Interaction | KLF1 interactions | 1.11e-07 | 37 | 64 | 5 | int:KLF1 | |
| Interaction | LHX2 interactions | 1.14e-07 | 183 | 64 | 8 | int:LHX2 | |
| Interaction | SMARCD2 interactions | 1.14e-07 | 183 | 64 | 8 | int:SMARCD2 | |
| Interaction | PBRM1 interactions | ARID1B MAPT SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A IFI16 | 1.20e-07 | 258 | 64 | 9 | int:PBRM1 |
| Interaction | LHX3 interactions | 1.24e-07 | 185 | 64 | 8 | int:LHX3 | |
| Interaction | BCL7A interactions | 1.24e-07 | 123 | 64 | 7 | int:BCL7A | |
| Interaction | TOP2B interactions | MED15 ERCC6 SMARCA2 SMARCA4 SMARCC2 SMARCD2 ARID1A IFI16 PSPC1 | 1.55e-07 | 266 | 64 | 9 | int:TOP2B |
| Interaction | SMARCB1 interactions | ARID1B POLR2A SMARCA2 SMARCA4 ARHGEF12 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 2.08e-07 | 364 | 64 | 10 | int:SMARCB1 |
| Interaction | EP300 interactions | TCF4 NCOA6 JUND PELP1 MAPT CSNK2A1 POLR2A TBX21 SMARCA2 SMARCA4 AUTS2 SMARCC2 SSBP4 ARID1A SRRM2 IFI16 PSPC1 CREBBP | 2.14e-07 | 1401 | 64 | 18 | int:EP300 |
| Interaction | PAX6 interactions | NCOA6 ARID1B CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A CREBBP | 2.19e-07 | 366 | 64 | 10 | int:PAX6 |
| Interaction | NFATC2 interactions | 2.25e-07 | 200 | 64 | 8 | int:NFATC2 | |
| Interaction | STK11IP interactions | 2.52e-07 | 83 | 64 | 6 | int:STK11IP | |
| Interaction | PHF10 interactions | 2.86e-07 | 139 | 64 | 7 | int:PHF10 | |
| Interaction | RBBP5 interactions | NCOA6 PELP1 CSNK2A1 SMARCA2 SMARCC2 SMARCD2 ARID1A SRRM2 CREBBP | 2.95e-07 | 287 | 64 | 9 | int:RBBP5 |
| Interaction | NFIB interactions | 3.30e-07 | 142 | 64 | 7 | int:NFIB | |
| Interaction | PIN1 interactions | TCF4 MAPT CSNK2A1 ZMIZ2 POLR2A PITX1 DIDO1 SSBP4 SSBP3 SRRM2 | 3.32e-07 | 383 | 64 | 10 | int:PIN1 |
| Interaction | CREBBP interactions | NCOA6 ARID1B PELP1 MAPT CSNK2A1 POLR2A TBX21 SMARCA2 SMARCA4 SMARCC2 ARID1A CREBBP | 3.41e-07 | 599 | 64 | 12 | int:CREBBP |
| Interaction | SMAD2 interactions | MED15 NCOA6 ARID1B MAPT SMARCA4 SMARCC2 SMARCD2 ARID1A PSPC1 CREBBP | 3.48e-07 | 385 | 64 | 10 | int:SMAD2 |
| Interaction | NR4A1 interactions | 3.51e-07 | 212 | 64 | 8 | int:NR4A1 | |
| Interaction | MBD3 interactions | ERCC6 CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 ARID1A SRRM2 CSNK2A3 | 3.72e-07 | 295 | 64 | 9 | int:MBD3 |
| Interaction | BRD3 interactions | MED15 MED30 CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 PLD1 ARID1A SRRM2 INO80D | 3.95e-07 | 494 | 64 | 11 | int:BRD3 |
| Interaction | CDK8 interactions | 4.98e-07 | 222 | 64 | 8 | int:CDK8 | |
| Interaction | PPARG interactions | 5.19e-07 | 307 | 64 | 9 | int:PPARG | |
| Interaction | ARID2 interactions | 5.48e-07 | 153 | 64 | 7 | int:ARID2 | |
| Interaction | GATA4 interactions | SALL3 CSNK2A1 SMARCA2 SMARCA4 SMARCC2 SMARCD2 SMARCD3 ARID1A SRRM2 PSPC1 | 6.33e-07 | 411 | 64 | 10 | int:GATA4 |
| Interaction | LHX8 interactions | 7.03e-07 | 53 | 64 | 5 | int:LHX8 | |
| Interaction | SNIP1 interactions | ARID1B POLR2A SMARCA2 SMARCA4 SMARCC2 SMARCD2 ARID1A SRRM2 PSPC1 CREBBP | 7.22e-07 | 417 | 64 | 10 | int:SNIP1 |
| Interaction | KLF4 interactions | 7.41e-07 | 160 | 64 | 7 | int:KLF4 | |
| Interaction | ASF1A interactions | 1.18e-06 | 249 | 64 | 8 | int:ASF1A | |
| Interaction | RBPJ interactions | 1.37e-06 | 254 | 64 | 8 | int:RBPJ | |
| Interaction | SFPQ interactions | ERCC6 HDAC5 MAPT CSNK2A1 SMARCA2 SMARCA4 SMARCC2 DIDO1 SRRM2 IFI16 PSPC1 | 1.43e-06 | 563 | 64 | 11 | int:SFPQ |
| Cytoband | 19p13.2 | 3.22e-04 | 229 | 65 | 4 | 19p13.2 | |
| GeneFamily | Cyclins|Mediator complex | 6.50e-05 | 33 | 43 | 3 | 1061 | |
| GeneFamily | Zinc fingers MIZ-type | 1.15e-04 | 7 | 43 | 2 | 85 | |
| GeneFamily | AT-rich interaction domain containing | 5.69e-04 | 15 | 43 | 2 | 418 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.60e-03 | 25 | 43 | 2 | 775 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.08e-02 | 66 | 43 | 2 | 722 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.23e-05 | 206 | 65 | 6 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.30e-05 | 208 | 65 | 6 | MM581 | |
| Coexpression | LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES | 4.21e-05 | 155 | 65 | 5 | M39246 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 5.50e-05 | 269 | 65 | 6 | M41203 | |
| Coexpression | GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP | 5.83e-05 | 166 | 65 | 5 | M7722 | |
| Coexpression | HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN | 7.13e-05 | 282 | 65 | 6 | M7623 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_UP | 7.53e-05 | 33 | 65 | 3 | M41050 | |
| Coexpression | TABULA_MURIS_SENIS_BRAIN_NON_MYELOID_NEURON_AGEING | JUND ERCC6 HDAC5 PELP1 IQSEC2 AUTS2 GRIA1 DIDO1 SMARCD3 SSBP4 | 1.13e-04 | 954 | 65 | 10 | MM3689 |
| Coexpression | GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP | 1.31e-04 | 197 | 65 | 5 | M4980 | |
| Coexpression | GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN | 1.31e-04 | 197 | 65 | 5 | M4421 | |
| Coexpression | GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP | 1.34e-04 | 198 | 65 | 5 | M9778 | |
| Coexpression | GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN | 1.34e-04 | 198 | 65 | 5 | M7480 | |
| Coexpression | GSE17721_CTRL_VS_LPS_24H_BMDC_UP | 1.37e-04 | 199 | 65 | 5 | M3703 | |
| Coexpression | GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP | 1.40e-04 | 200 | 65 | 5 | M9317 | |
| Coexpression | GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN | 1.40e-04 | 200 | 65 | 5 | M8001 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN | 1.40e-04 | 200 | 65 | 5 | M5186 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | 1.40e-04 | 200 | 65 | 5 | M9952 | |
| Coexpression | GSE17721_CTRL_VS_LPS_4H_BMDC_UP | 1.40e-04 | 200 | 65 | 5 | M3689 | |
| Coexpression | GSE11924_TH2_VS_TH17_CD4_TCELL_DN | 1.40e-04 | 200 | 65 | 5 | M3165 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 1.68e-04 | 634 | 65 | 8 | M40866 | |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN | 1.92e-04 | 45 | 65 | 3 | M13714 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | ESRP2 ILDR2 TCF4 SALL3 PITX1 MED14 AUTS2 SYNPO ZMIZ1 SSBP3 IFI16 | 1.69e-05 | 769 | 64 | 11 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| ToppCell | facs-Trachea-3m|Trachea / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.56e-08 | 197 | 65 | 7 | e77016d64b1cac9825fec7cfe5071f1567401187 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-08 | 197 | 65 | 7 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-07 | 189 | 65 | 6 | 965e0e388251e7318f8b463816dc96ccb4658677 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T6|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 6.42e-06 | 179 | 65 | 5 | 14fc8ccb6b215063d747643f47d780d2b237eb67 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-06 | 186 | 65 | 5 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|Liver / Manually curated celltypes from each tissue | 9.72e-06 | 195 | 65 | 5 | 972b09697b7b66fb8a27dfc0c0b05a844121f055 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo|Liver / Manually curated celltypes from each tissue | 9.72e-06 | 195 | 65 | 5 | c29c4ae95a756e3ced0f0747bbfe343590e5b8ab | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 9.96e-06 | 196 | 65 | 5 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-05 | 198 | 65 | 5 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.07e-05 | 199 | 65 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 65 | 5 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 65 | 5 | b70b7adb7c187e6253c7f0bb4c1f09c85ef7142c | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 1.10e-05 | 200 | 65 | 5 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | Control-NK|World / Disease group and Cell class | 5.70e-05 | 143 | 65 | 4 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 8.60e-05 | 159 | 65 | 4 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.81e-05 | 160 | 65 | 4 | 8bb873704895c3b35bba8af78fedbabf7df42e71 | |
| ToppCell | Influenza_Severe-B_memory|World / Disease group and Cell class | 9.24e-05 | 162 | 65 | 4 | 21eb96cd4fecd85dd6acbbc3760944fa1a7cff42 | |
| ToppCell | Influenza_Severe-B_memory|Influenza_Severe / Disease group and Cell class | 9.92e-05 | 165 | 65 | 4 | 51172acaeb667b34b8b8c7878d67cfa0c4a2dffc | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.02e-04 | 166 | 65 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-NK_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 167 | 65 | 4 | aef22535a76e93472bcedacbb2c6991f3c9c8cd5 | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 1.06e-04 | 168 | 65 | 4 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | severe_influenza-B_memory|World / disease group, cell group and cell class (v2) | 1.16e-04 | 172 | 65 | 4 | 0ff38f9431cec73250c580a6010cb7891a3fe3f1 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-04 | 172 | 65 | 4 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.19e-04 | 173 | 65 | 4 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 176 | 65 | 4 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 176 | 65 | 4 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | facs-Brain_Myeloid-Striatum|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.30e-04 | 177 | 65 | 4 | efb1990fd1d216f64261e81017299783afb24a1e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.42e-04 | 181 | 65 | 4 | 12ff56fa2949c8d53360cdf2cacfd326e65b54aa | |
| ToppCell | severe_influenza-B_memory|severe_influenza / disease group, cell group and cell class (v2) | 1.42e-04 | 181 | 65 | 4 | 92e572c92109a6dae0f73138c57c3bbd2e0a2f36 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-04 | 182 | 65 | 4 | 33afbb7c4352b03266501b1f4f0e751c12c7350d | |
| ToppCell | PBMC-Severe-Lymphocyte-B-B_cell-B_memory-B_memory-0|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.64e-04 | 188 | 65 | 4 | 229108e7e3db49e1cfd747d69e338394139d95b3 | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-04 | 188 | 65 | 4 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | 1.67e-04 | 189 | 65 | 4 | ea3aa3ef38f1d405bb527ae383cd12c551a3dd6f | |
| ToppCell | Healthy_donor-B_memory|Healthy_donor / disease group, cell group and cell class (v2) | 1.71e-04 | 190 | 65 | 4 | 46104a521f00d399315deca86699cb261b2795d6 | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|IPF / Disease state, Lineage and Cell class | 1.71e-04 | 190 | 65 | 4 | b4e35cbfe4d43d2cd51f29c3085e4d9b1012e6f0 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.74e-04 | 191 | 65 | 4 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.74e-04 | 191 | 65 | 4 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.81e-04 | 193 | 65 | 4 | 097a244cf37ce6c1ace9bae56beb7de59442cd6b | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.85e-04 | 194 | 65 | 4 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-04 | 194 | 65 | 4 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-04 | 194 | 65 | 4 | 52e09b14159b609af00264a8f38accf37ba8f464 | |
| ToppCell | Mild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.88e-04 | 195 | 65 | 4 | 0a3221e4d1fa31a35868bdda0f0cc873c233b407 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.88e-04 | 195 | 65 | 4 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|myeloid / Lineage, cell class and subclass | 1.88e-04 | 195 | 65 | 4 | 15ba9c5f6ecb6ae2c603e6b036eb92b00b46f13f | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.88e-04 | 195 | 65 | 4 | cd011433b3b9bfb1adb13eca2f3f2a5db024cd94 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.92e-04 | 196 | 65 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Healthy-CD4+_CTL|World / disease group, cell group and cell class | 1.92e-04 | 196 | 65 | 4 | 6a623eeb2ba8d4e16543820bcbba41eecbd00ed2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-04 | 196 | 65 | 4 | 08714b70ddaee7d11397c1dd4a287d412edd90f7 | |
| ToppCell | severe_COVID-19-B_memory|severe_COVID-19 / disease group, cell group and cell class (v2) | 1.92e-04 | 196 | 65 | 4 | c6e00cb59a88b9903cca233cefe05f80c5ea4153 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-04 | 196 | 65 | 4 | 5bcc959db7deb34d5a32d3464367d47d4945cdaf | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.96e-04 | 197 | 65 | 4 | f84263c5aaf3a5cd46d6e06358e8de6c6e6eaa3b | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD8+_Memory_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.96e-04 | 197 | 65 | 4 | 836061acd7f0d5de89b16f52ec679bdf09eac9db | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.96e-04 | 197 | 65 | 4 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | facs-Diaphragm-Limb_Muscle-3m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-04 | 197 | 65 | 4 | b0e2ea81308bce289cb7cbea0e27de1d01afeed2 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD8-Tem/emra_CD8|Liver / Manually curated celltypes from each tissue | 2.00e-04 | 198 | 65 | 4 | 2fc2a4638c458ae793ac090a29d27b75fc9e6af6 | |
| ToppCell | COVID-19-Heart-Mito_EC|Heart / Disease (COVID-19 only), tissue and cell type | 2.00e-04 | 198 | 65 | 4 | 3cc34b5d333abba11ab846c26fb4477051958465 | |
| ToppCell | Caecum-T_cell-Th1|T_cell / Region, Cell class and subclass | 2.04e-04 | 199 | 65 | 4 | 13a80e6d3cf9c831edbe0644545071153e35f82b | |
| ToppCell | COVID_vent-Lymphocytic-ILC|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.04e-04 | 199 | 65 | 4 | e3ff7fa1b1de1aaf6b46cdf49afa95bad457728a | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-04 | 199 | 65 | 4 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 2.04e-04 | 199 | 65 | 4 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 2.04e-04 | 199 | 65 | 4 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | facs-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.04e-04 | 199 | 65 | 4 | c11e0044d3cc37f6bb26df033ad4448b419addfc | |
| ToppCell | COVID_vent-Lymphocytic-ILC-NK_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.04e-04 | 199 | 65 | 4 | 5f914962e2572b0c6372465b81b7496fa663d93c | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 199 | 65 | 4 | 67f78c070c56e44fba36542041bf7fa1c291807c | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-04 | 199 | 65 | 4 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 199 | 65 | 4 | 1ae244b563f85c1ee8d22698f478c842a4d9c7f5 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | bcd1cc96197929d6011903803b6f4ccdcf52b4ce | |
| ToppCell | COVID-19|World / group, cell type (main and fine annotations) | 2.08e-04 | 200 | 65 | 4 | ac38a468559c33ee00152735ce6e408f3f48df84 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 5c092b2ecc081b5d04476c56333c338cd89ab984 | |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 81e76508c9050d533853d5fd2f3097b27613d836 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Gen_Intermediate|Control_saline / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 041a34080120c9f613373c20dcc366292f558040 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.08e-04 | 200 | 65 | 4 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | b1fadb2b5e37e0f51e079d8409c2647eef68dc3b | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.08e-04 | 200 | 65 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | mild-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.08e-04 | 200 | 65 | 4 | 109f673a4967ffa52270a0b4f818b3461288db44 | |
| ToppCell | VE|World / Condition, Cell_class and T cell subcluster | 2.08e-04 | 200 | 65 | 4 | 8ae7cb81de3ffac5acdf3466d4b516d80cac95d3 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | f15fffefe372005c33e31845982e2d2714ac26af | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | a1fa6bae5a688faf488d6925cd3fad725dfa916b | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 89a6da2bdedc6b1ad0675c8753bf2b763a99af6a | |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | d01cec331be3b03cef80e9536fc531285bcf00f6 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a | |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | abf4ba5fcb54cdeada0da1a8b956a30aa47679e4 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.08e-04 | 200 | 65 | 4 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 432384faeade8e609154fab3d96c955a8ec868dd | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 3585484c7e24e941708bee471ca607d8ccee74e6 | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 2.08e-04 | 200 | 65 | 4 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.08e-04 | 200 | 65 | 4 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.08e-04 | 200 | 65 | 4 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | 2.08e-04 | 200 | 65 | 4 | 4bb609a284d4e6066f17470a1736076aa4a1f84c | |
| Drug | Benzthiazide [91-33-8]; Up 200; 9.2uM; MCF7; HT_HG-U133A | SEC24D CDC42BPA IRF2BP1 MAPT ITSN1 POLR2A AUTS2 ARID1A CREBBP | 4.32e-09 | 198 | 64 | 9 | 3329_UP |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 7.36e-08 | 195 | 64 | 8 | 6098_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 4.96e-07 | 170 | 64 | 7 | 1050_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.37e-07 | 172 | 64 | 7 | 6439_DN | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A | 1.21e-06 | 194 | 64 | 7 | 3861_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; PC3; HT_HG-U133A | 1.25e-06 | 195 | 64 | 7 | 6626_DN | |
| Drug | Spiramycin [8025-81-8]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.29e-06 | 196 | 64 | 7 | 3844_DN | |
| Drug | Thalidomide [50-35-1]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.29e-06 | 196 | 64 | 7 | 7288_DN | |
| Drug | Clomipramine hydrochloride [17321-77-6]; Up 200; 11.4uM; HL60; HG-U133A | 1.29e-06 | 196 | 64 | 7 | 1566_UP | |
| Drug | Benfotiamine [22457-89-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 1.34e-06 | 197 | 64 | 7 | 3837_DN | |
| Drug | Acemetacin [53164-05-9]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.43e-06 | 199 | 64 | 7 | 6361_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.03e-06 | 169 | 64 | 6 | 6064_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 8.88e-06 | 172 | 64 | 6 | 4112_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 8.88e-06 | 172 | 64 | 6 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.01e-05 | 176 | 64 | 6 | 6784_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 1.05e-05 | 177 | 64 | 6 | 1645_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.05e-05 | 177 | 64 | 6 | 3227_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.08e-05 | 178 | 64 | 6 | 7245_DN | |
| Drug | scriptaid; Down 200; 10uM; PC3; HT_HG-U133A | 1.23e-05 | 182 | 64 | 6 | 6896_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.30e-05 | 184 | 64 | 6 | 7555_DN | |
| Drug | 8-bromoguanine | 1.50e-05 | 53 | 64 | 4 | CID000076473 | |
| Drug | CP-319743 [172078-87-4]; Up 200; 10uM; PC3; HT_HG-U133A | 1.52e-05 | 189 | 64 | 6 | 7537_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.52e-05 | 189 | 64 | 6 | 6966_UP | |
| Drug | Nitrofural [59-87-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | 1.61e-05 | 191 | 64 | 6 | 6721_DN | |
| Drug | Clotrimazole [23593-75-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.66e-05 | 192 | 64 | 6 | 6207_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.71e-05 | 193 | 64 | 6 | 6223_UP | |
| Drug | Mebhydroline 1,5-naphtalenedisulfonate [6153-33-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.71e-05 | 193 | 64 | 6 | 4795_UP | |
| Drug | Ajmaline [4360-12-7]; Down 200; 12.2uM; HL60; HG-U133A | 1.71e-05 | 193 | 64 | 6 | 1749_DN | |
| Drug | 17-AAG; Down 200; 1uM; PC3; HT_HG-U133A | 1.71e-05 | 193 | 64 | 6 | 5919_DN | |
| Drug | Sulfamethazine sodium salt [1981-58-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 1.71e-05 | 193 | 64 | 6 | 4322_UP | |
| Drug | Fusaric acid [536-69-6]; Up 200; 22.4uM; MCF7; HT_HG-U133A | 1.76e-05 | 194 | 64 | 6 | 3245_UP | |
| Drug | Nystatine [1400-61-9]; Up 200; 4.4uM; PC3; HT_HG-U133A | 1.76e-05 | 194 | 64 | 6 | 4223_UP | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 1.81e-05 | 195 | 64 | 6 | 1630_UP | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.81e-05 | 195 | 64 | 6 | 6338_DN | |
| Drug | Naringenine [480-41-1]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 1.81e-05 | 195 | 64 | 6 | 3278_UP | |
| Drug | Flunarizine dihydrochloride [30484-77-6]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.87e-05 | 196 | 64 | 6 | 7252_UP | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; HL60; HT_HG-U133A | 1.87e-05 | 196 | 64 | 6 | 2331_UP | |
| Drug | Asiaticoside [16830-15-2]; Up 200; 4.2uM; PC3; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 7244_UP | |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; MCF7; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 5312_UP | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; PC3; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 2103_UP | |
| Drug | Arcaine sulfate [14923-17-2]; Down 200; 14.8uM; PC3; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 6629_DN | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.92e-05 | 197 | 64 | 6 | 3209_UP | |
| Drug | Nitrofurantoin [67-20-9]; Up 200; 16.8uM; PC3; HT_HG-U133A | 1.98e-05 | 198 | 64 | 6 | 7373_UP | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 1.98e-05 | 198 | 64 | 6 | 5444_DN | |
| Drug | Viomycin sulfate [37883-00-4]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 3541_UP | |
| Drug | Methylhydantoin-5-(D) [55147-68-7]; Down 200; 35uM; PC3; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 3994_DN | |
| Drug | Laudanosine (R,S) [1699-51-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 2.03e-05 | 199 | 64 | 6 | 7030_DN | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; PC3; HT_HG-U133A | 2.09e-05 | 200 | 64 | 6 | 6628_DN | |
| Drug | cobalt(II) chloride hexahydrate; Down 200; 100uM; MCF7; HG-U133A | 2.09e-05 | 200 | 64 | 6 | 379_DN | |
| Drug | AC1L2E0P | 2.44e-05 | 307 | 64 | 7 | CID000019390 | |
| Drug | prochloraz | 7.56e-05 | 155 | 64 | 5 | CID000073665 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 9.59e-05 | 163 | 64 | 5 | 7285_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.02e-04 | 165 | 64 | 5 | 2835_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.14e-04 | 169 | 64 | 5 | 5572_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.17e-04 | 170 | 64 | 5 | 3791_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.34e-04 | 175 | 64 | 5 | 6316_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.37e-04 | 176 | 64 | 5 | 2639_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.37e-04 | 176 | 64 | 5 | 7499_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.37e-04 | 176 | 64 | 5 | 6932_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.37e-04 | 176 | 64 | 5 | 1535_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.45e-04 | 178 | 64 | 5 | 1112_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 1.49e-04 | 179 | 64 | 5 | 6609_DN | |
| Drug | Methyl benzethonium chloride [25155-18-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.49e-04 | 179 | 64 | 5 | 6045_UP | |
| Drug | scriptaid; Down 200; 10uM; MCF7; HT_HG-U133A | 1.49e-04 | 179 | 64 | 5 | 6901_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.53e-04 | 180 | 64 | 5 | 4821_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.57e-04 | 181 | 64 | 5 | 7077_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.57e-04 | 181 | 64 | 5 | 6951_DN | |
| Drug | testosterone-3-carboxymethyloxime-bovine serum albumin conjugate | 1.74e-04 | 185 | 64 | 5 | ctd:C045037 | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.78e-04 | 186 | 64 | 5 | 6874_DN | |
| Drug | Mometasone furoate [83919-23-7]; Down 200; 7.6uM; PC3; HT_HG-U133A | 1.87e-04 | 188 | 64 | 5 | 5116_DN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; PC3; HT_HG-U133A | 1.96e-04 | 190 | 64 | 5 | 7070_UP | |
| Drug | Gliquidone [33342-05-1]; Up 200; 7.6uM; PC3; HT_HG-U133A | 1.96e-04 | 190 | 64 | 5 | 7301_UP | |
| Drug | GSK-3 Inhibitor IX; Down 200; 0.5uM; PC3; HT_HG-U133A | 2.06e-04 | 192 | 64 | 5 | 7106_DN | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 2.06e-04 | 192 | 64 | 5 | 7427_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.06e-04 | 192 | 64 | 5 | 6435_DN | |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; HL60; HT_HG-U133A | 2.06e-04 | 192 | 64 | 5 | 2919_DN | |
| Drug | 0317956-0000 [391210-11-0]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.06e-04 | 192 | 64 | 5 | 3858_DN | |
| Drug | WY-14643; Down 200; 100uM; PC3; HG-U133A | 2.06e-04 | 192 | 64 | 5 | 464_DN | |
| Drug | Promegestone | 2.09e-04 | 41 | 64 | 3 | ctd:D011397 | |
| Drug | troglitazone; Down 200; 10uM; PC3; HG-U133A | 2.11e-04 | 193 | 64 | 5 | 431_DN | |
| Drug | Cetirizine dihydrochloride [83881-52-1]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 2829_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; PC3; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 4186_DN | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Up 200; 13.8uM; PC3; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 1830_UP | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.11e-04 | 193 | 64 | 5 | 6868_UP | |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 5362_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; PC3; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 1217_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 3807_DN | |
| Drug | Trichlorfon [52-68-6]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 1675_DN | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 3539_DN | |
| Drug | Epivincamine [6835-99-0]; Up 200; 11.2uM; HL60; HG-U133A | 2.16e-04 | 194 | 64 | 5 | 1783_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 3384_DN | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 3828_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; HL60; HG-U133A | 2.16e-04 | 194 | 64 | 5 | 2009_DN | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 4272_DN | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 2.16e-04 | 194 | 64 | 5 | 3779_DN | |
| Drug | Ozagrel hydrochloride [78712-43-3]; Up 200; 15.2uM; HL60; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 2942_UP | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 6059_DN | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 6101_DN | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 1uM; PC3; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 4333_DN | |
| Drug | Ethionamide [536-33-4]; Down 200; 24uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 64 | 5 | 4418_DN | |
| Disease | alcohol use disorder (implicated_via_orthology) | ARID1B SMARCA2 SMARCA4 AUTS2 SMARCC2 SMARCD2 SMARCD3 ARID1A SRRM2 CREBBP | 1.40e-11 | 195 | 64 | 10 | DOID:1574 (implicated_via_orthology) |
| Disease | Coffin-Siris syndrome | 5.20e-11 | 13 | 64 | 5 | C0265338 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.00e-10 | 5 | 64 | 4 | C3281201 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 2.51e-09 | 9 | 64 | 4 | DOID:1925 (implicated_via_orthology) | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 8.10e-07 | 9 | 64 | 3 | DOID:0050340 (implicated_via_orthology) | |
| Disease | Burkitt Lymphoma | 1.13e-06 | 36 | 64 | 4 | C0006413 | |
| Disease | Burkitt Leukemia | 4.35e-06 | 15 | 64 | 3 | C4721444 | |
| Disease | African Burkitt's lymphoma | 4.35e-06 | 15 | 64 | 3 | C0343640 | |
| Disease | central nervous system disease (implicated_via_orthology) | 5.34e-06 | 16 | 64 | 3 | DOID:331 (implicated_via_orthology) | |
| Disease | Sezary Syndrome | 2.74e-05 | 27 | 64 | 3 | C0036920 | |
| Disease | irritability measurement | 3.10e-05 | 82 | 64 | 4 | EFO_0009594 | |
| Disease | Adenoid Cystic Carcinoma | 6.75e-05 | 100 | 64 | 4 | C0010606 | |
| Disease | testosterone measurement | NCOA6 ARID1B IRF2BP1 MAPT POLR2A IQSEC2 RTL9 SMARCA2 AUTS2 ZMIZ1 ARID1A | 8.50e-05 | 1275 | 64 | 11 | EFO_0004908 |
| Disease | Cocaine-Related Disorders | 1.24e-04 | 117 | 64 | 4 | C0236736 | |
| Disease | AUTISM, SUSCEPTIBILITY TO, 15 | 1.29e-04 | 8 | 64 | 2 | C2677504 | |
| Disease | biological sex | 1.44e-04 | 230 | 64 | 5 | PATO_0000047 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 1.57e-04 | 48 | 64 | 3 | C1862941 | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 1.57e-04 | 48 | 64 | 3 | C4551993 | |
| Disease | Cocaine Abuse | 1.70e-04 | 127 | 64 | 4 | C0009171 | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 1.77e-04 | 50 | 64 | 3 | C1862939 | |
| Disease | sitting height ratio | 1.88e-04 | 51 | 64 | 3 | EFO_0007118 | |
| Disease | Global developmental delay | 2.03e-04 | 133 | 64 | 4 | C0557874 | |
| Disease | neuroblastoma (is_implicated_in) | 2.06e-04 | 10 | 64 | 2 | DOID:769 (is_implicated_in) | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.41e-04 | 139 | 64 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Cocaine Dependence | 2.41e-04 | 139 | 64 | 4 | C0600427 | |
| Disease | C-reactive protein measurement | TCF4 NCOA6 ZMIZ2 SMARCA4 SMARCC2 GRIA1 ZMIZ1 SSBP4 IFI16 MAML3 | 2.55e-04 | 1206 | 64 | 10 | EFO_0004458 |
| Disease | cancer (implicated_via_orthology) | 2.93e-04 | 268 | 64 | 5 | DOID:162 (implicated_via_orthology) | |
| Disease | Craniofacial Abnormalities | 3.73e-04 | 156 | 64 | 4 | C0376634 | |
| Disease | Sarcoma, Spindle Cell | 4.14e-04 | 14 | 64 | 2 | C0205945 | |
| Disease | Sarcoma, Epithelioid | 4.14e-04 | 14 | 64 | 2 | C0205944 | |
| Disease | diet measurement | 4.17e-04 | 1049 | 64 | 9 | EFO_0008111 | |
| Disease | Microcephaly | 4.22e-04 | 67 | 64 | 3 | C0025958 | |
| Disease | dyslexia | 4.30e-04 | 162 | 64 | 4 | EFO_0005424 | |
| Disease | Non-steroidal anti-inflammatory and antirheumatic product use measurement | 4.77e-04 | 15 | 64 | 2 | EFO_0009935 | |
| Disease | hepcidin:transferrin saturation ratio | 4.77e-04 | 15 | 64 | 2 | EFO_0007902 | |
| Disease | body surface area | 4.78e-04 | 643 | 64 | 7 | EFO_0022196 | |
| Disease | monocyte count | TCF4 JUND CDC42BPA ZMIZ2 ARHGEF12 DIDO1 ZMIZ1 PAN3 SSBP4 SSBP3 | 5.19e-04 | 1320 | 64 | 10 | EFO_0005091 |
| Disease | household income | 5.21e-04 | 304 | 64 | 5 | EFO_0009695 | |
| Disease | sexual dimorphism measurement | NCOA6 CDC42BPA HDAC5 POLR2A PITX1 SMARCA4 LTBP3 ZMIZ1 ARID1A | 6.10e-04 | 1106 | 64 | 9 | EFO_0021796 |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 6.17e-04 | 17 | 64 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | asparaginase hypersensitivity | 6.35e-04 | 77 | 64 | 3 | EFO_0004881 | |
| Disease | Feeding difficulties | 6.93e-04 | 18 | 64 | 2 | C0232466 | |
| Disease | neutrophil count | ILDR2 CDC42BPA MAPT IQSEC2 ARHGEF12 ZMIZ1 SSBP4 ARID1A IFI16 CREBBP | 7.41e-04 | 1382 | 64 | 10 | EFO_0004833 |
| Disease | Epilepsy, Cryptogenic | 7.63e-04 | 82 | 64 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 7.63e-04 | 82 | 64 | 3 | C0751111 | |
| Disease | Aura | 7.63e-04 | 82 | 64 | 3 | C0236018 | |
| Disease | neuroticism measurement, wellbeing measurement, depressive symptom measurement | 7.73e-04 | 19 | 64 | 2 | EFO_0007006, EFO_0007660, EFO_0007869 | |
| Disease | Osteoarthritis of hip | 8.58e-04 | 20 | 64 | 2 | C0029410 | |
| Disease | Sarcoma | 9.47e-04 | 21 | 64 | 2 | C1261473 | |
| Disease | QT interval | 1.05e-03 | 534 | 64 | 6 | EFO_0004682 | |
| Disease | Neurodevelopmental Disorders | 1.10e-03 | 93 | 64 | 3 | C1535926 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 1.10e-03 | 93 | 64 | 3 | DOID:3525 (biomarker_via_orthology) | |
| Disease | Carcinoma of lung | 1.14e-03 | 23 | 64 | 2 | C0684249 | |
| Disease | vital capacity | 1.34e-03 | 1236 | 64 | 9 | EFO_0004312 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 1.39e-03 | 101 | 64 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | glucose measurement | 1.41e-03 | 380 | 64 | 5 | EFO_0004468 | |
| Disease | Weight Gain | 1.43e-03 | 102 | 64 | 3 | C0043094 | |
| Disease | taste liking measurement | 1.55e-03 | 388 | 64 | 5 | EFO_0010155 | |
| Disease | triacylglycerol 54:7 measurement | 1.69e-03 | 28 | 64 | 2 | EFO_0010425 | |
| Disease | eosinophil measurement | 1.69e-03 | 108 | 64 | 3 | EFO_0803540 | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 1.73e-03 | 398 | 64 | 5 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | Epilepsy | 1.73e-03 | 109 | 64 | 3 | C0014544 | |
| Disease | Developmental Academic Disorder | 1.81e-03 | 29 | 64 | 2 | C1330966 | |
| Disease | Learning Disorders | 1.81e-03 | 29 | 64 | 2 | C0023186 | |
| Disease | level of Sphingomyelin (d42:2) in blood serum | 1.81e-03 | 29 | 64 | 2 | OBA_2045183 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 1.81e-03 | 29 | 64 | 2 | C0496920 | |
| Disease | Learning Disturbance | 1.81e-03 | 29 | 64 | 2 | C0751263 | |
| Disease | Adult Learning Disorders | 1.81e-03 | 29 | 64 | 2 | C0751262 | |
| Disease | Learning Disabilities | 1.81e-03 | 29 | 64 | 2 | C0751265 | |
| Disease | Schizoaffective Disorder | 1.81e-03 | 29 | 64 | 2 | C0036337 | |
| Disease | Ovarian Carcinoma | 1.94e-03 | 30 | 64 | 2 | C0029925 | |
| Disease | antihyperlipidemic drug use measurement | 2.02e-03 | 115 | 64 | 3 | EFO_0803367 | |
| Disease | Severe Congenital Microcephaly | 2.07e-03 | 31 | 64 | 2 | C3853041 | |
| Disease | neutrophil percentage of leukocytes | 2.07e-03 | 610 | 64 | 6 | EFO_0007990 | |
| Disease | JT interval | 2.08e-03 | 248 | 64 | 4 | EFO_0007885 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSSGAMSVGMGQPPA | 801 | Q92793 | |
| MPPGRTGMGTPGSQM | 1981 | Q92793 | |
| HPAMSPGTPGPTMGR | 581 | Q8NFD5 | |
| MTPSSPGMSQQGGPG | 986 | Q8NFD5 | |
| EAGTSQPMPPGMGTS | 606 | Q9HBB8 | |
| DAEPGPSSLGSMLMP | 216 | Q03468 | |
| PIMTSPHSPGASGNM | 171 | Q9NZN5 | |
| SGMCPPPGGMNRKTQ | 881 | O14497 | |
| DAEPGPSSLGSMLMP | 216 | P0DP91 | |
| GFPHPEMTTSMGRGP | 7656 | Q8WXI7 | |
| PMQSSVPPGSGGMVS | 706 | Q96JK9 | |
| MMPAAGAAGGPGSRP | 1396 | Q5JU85 | |
| MDMGNPGTLSPTKPG | 131 | P15884 | |
| MSVPGTPGAMEPAGE | 1 | Q5HYC2 | |
| LFPGAPPTAAAGSMM | 31 | P17535 | |
| PGPLASMPMTVGVTG | 1016 | Q8WXX7 | |
| LGAMGQPMSLSGQPP | 116 | Q96RN5 | |
| PVGMSGQVAGSPMLP | 981 | Q9ULI4 | |
| MAAPASVMGPLGPSA | 1 | A1L453 | |
| MPSVGSMPSAGPMPS | 671 | Q8IZL8 | |
| MSTPPLAASGMAPGP | 1 | Q96HR3 | |
| SGPSPAARMPGMSPA | 1116 | O60244 | |
| PGGNVSSSMMAPGPN | 186 | Q14686 | |
| PSMGSPATAGLAPGM | 321 | Q58A45 | |
| TSPSSMARVPGPMGP | 301 | P0CG12 | |
| QARMGSSSMPGGSTP | 331 | Q8NEV1 | |
| CLSGFMGMDIPPPSG | 366 | P07339 | |
| SAPAFGMGGIASMPP | 111 | Q15811 | |
| VPMASPAPGRLGAMS | 646 | Q9BTC0 | |
| QARMGSSSMPGGSTP | 331 | P68400 | |
| MPGPRGAAGGLAPEM | 1 | Q9NS15 | |
| PPSPAGAGMSTAMGR | 151 | Q16666 | |
| KMPNGLDGMSLSPPG | 121 | Q53TQ3 | |
| PVLPRAMPSSMGGGG | 36 | Q9UQL6 | |
| PCMSHSSGMPLGATG | 891 | P42261 | |
| GGSALPPLGSMASGM | 1246 | Q9BXA9 | |
| GSMPGLMPPGLLAAA | 156 | Q8IU81 | |
| MCPQLAGAGSMGSPG | 1 | O15547 | |
| AGMSPSLAGMSPGAG | 71 | Q9Y261 | |
| SGVMPTQTMPAPGSG | 356 | Q8NET4 | |
| PMPLPRATASGCGMG | 1041 | Q8NET4 | |
| PSSMGPGAVPGMPNS | 226 | P78337 | |
| SRSNFPMGPGSDGPM | 306 | Q9BWW4 | |
| QAGGSMMDGPGPRIP | 2151 | Q9UQ35 | |
| MCSTPGMPAPGASLA | 1 | O60522 | |
| PGPGPSPGSVHSMMG | 31 | P51531 | |
| SPGSVHSMMGPSPGP | 36 | P51531 | |
| GPSLGSLPPAAMESM | 506 | Q13393 | |
| MMTASPSPGPGPRVA | 116 | Q8N3V7 | |
| SPGPSPGSAHSMMGP | 31 | P51532 | |
| MGSPAVRPGLAPAGM | 51 | Q6STE5 | |
| HPSGPMQGVPRGSSM | 946 | Q7L7X3 | |
| VLMGGTLGRSGMSPP | 561 | Q9H6T0 | |
| PMPSPSEGSLSSGGM | 1661 | Q5VT25 | |
| PGTPMDGGSIGFSMS | 1011 | Q9NZP6 | |
| TPPSMMPGAVPGSGH | 1056 | Q8TAQ2 | |
| ASPTGMMKPAGPLGA | 36 | O94855 | |
| RMPMAGLQVGPPAGS | 81 | Q92925 | |
| AAAAGMGPRPMAGST | 421 | Q7Z6J0 | |
| GSTIMPMSPDGLFPA | 171 | Q8NCJ5 | |
| PPSQMGSPMGSRTGS | 471 | Q8WXF1 | |
| MNSMAGGAPSPGPAD | 251 | Q9UBI4 | |
| SVPLGGAPSSGMLMD | 261 | Q71H61 | |
| AAAPSPVMGSMAPGD | 96 | Q9BWG4 | |
| AGPTGMFFGSAPSPM | 1496 | P24928 | |
| MFFGSAPSPMGGISP | 1501 | P24928 | |
| GPPGLSHQLMSGMPG | 141 | P10636 | |
| MGPAGSPSGSSMMPG | 61 | Q8NF64 | |
| SPSGSSMMPGVAGGS | 66 | Q8NF64 | |
| FSPATGVMGPPSMSG | 861 | Q8NF64 | |
| GVMGPPSMSGAGEAP | 866 | Q8NF64 | |
| PGCGDMLTGTEPMPG | 6 | Q9UL17 | |
| MNQPGPRGPASMGGS | 331 | Q9ULJ6 | |
| PRGPASMGGSMNPAS | 336 | Q9ULJ6 | |
| AGLGLGPGLSPASMM | 416 | Q9NW07 | |
| GPGLSPASMMRPGQV | 421 | Q9NW07 | |
| MATAPGPAGIAMGSV | 1 | O15049 |